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INTRODUCTION 
In  the  modern  era,  orthopaedic  implants  have  revolutionized  the  
treatment  of  bone  fractures  and  non  infectious  arthritis.  Today  implant  
surgery  has  become  one  of  the  commonest  orthopaedic  operations,  because  
of  the  success  of  this  procedure  in  restoring  function  of  bones  and  joints.  
This  is  the  major  procedure  to  alleviate  pain  and  improve  mobility  in  
people  with  bone  fracture  and  damaged  joints.   
Less  than  10%  of  prosthesis  recipients  develop  implant-associated  
complications  during  their  lifetime,  predominantly  implant  failure.  
However,  the  absolute  number  of  patients  with  infection  continuously  
increases  as  the  number  of  patients  requiring  such  implants  grows. 
Implant  failure  are  of  two  types,  loosening  from  joint  infection  is  
referred  to  as  septic  failure,  loosening  from  non  infectious  reasons  such  
as  bone  fracture,  brittle  bones  that  cannot  hold  the  implant  or  some  other  
mechanical  problem  is  called  aseptic  (without  infection)  failure. 
In  the  UK  and  USA,  about  800000  joint  arthroplasties  are  done  
annually,  with  projections  to  greater  than  4  million  by  2030[3].  The  
incidence  of  infection  following  elective  orthopaedic  surgery  is  in  the  
range  of  0.7%  to  4.2%,  while  incidence  can  be  much  higher  in  trauma  
cases  where  infection  rates  range  from  1%  of  closed  fractures  to  more  
than  30%  in  open  fractures[7].  It  is  a  challenging  task  to  treat  ODRI  
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which  may  lead  to  implant  replacement,  and  in  severe  cases  amputation  
and  even  mortality. 
Definition:   
Orthopaedic  implants  can  be  defined  [1]  as  medical  devices  used  
to  replace  or  provide  fixation  of  bone  or  to  replace  articulating  surface  
of  a  joint.  In  simpler  words  orthopaedic  implants  are  used  to  either  assist  
or  replace  damaged  or  troubled  bones  and  joints.  Orthopaedic  implants  
are  mainly  made  from  stainless  steel  and  titanium  alloys  for  strength  and  
lined  with  plastic  to  act  as  artificial  cartilage  in  order  to  reduce  the  stress  
at  the  articulating  surfaces.  Some  implants  are  cemented  into  place  and  
others  are  pressed  to  fit  so  that  the  bone  can  grow  into  the  implant  for  
strength. 
Some  examples  of  orthopaedic  implants  [1]  are,  a)  Orthopaedic  
plates  b)  Orthopaedic  nails  c)  Orthopaedic  screws   
The  key  factor  that  guides  bone  healing  is  the  interfragmentary  
movement,  which  determines  the  tissue  strain  and  consequently  the    
cellular  reaction  in  the  fracture  healing  zone.  Thus  the  methods  of  fracture  
fixation  will  be  evaluated  by  considering  their  ability  to  reduce  the  
interfragmentary  movement.[1]. 
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Classification  of  orthopaedic  fixation  devices.[1] 
1)Internal  fixation  devices:  Screws,  plates,  wires  and  pins,  intramedullary  
rods  &    nails,  and  spinal  fixation  devices. 
2)  External  fixation  devices:  a)  Fracture  fixation  devices-  Radius,  Tibia,  
Pelvis.  b)  Bone  lengthening-  IIizarov  device 
Classification  of  Orthopaedic  Device  Related  Infections(ODRI) 
Definition:   
An  implant  associated  infection  is  defined  as  a  host  immune  
response  to  one  or  more  microbial  pathogens  on  an  indwelling  implant[12].   
Orthopaedic  device  related  infections  occur  per  operatively  by  
bacterial  contamination  of  the  surgical  site  during  surgery  or  immediately  
thereafter.  It  could  be  a  haematogenous  microbial  spread  through  blood  
from  a  distant  focus  of  infection  or  contiguously  by  direct  or  lymphatic  
spread  from  an  adjacent  infectious  focus  or  by  penetrating  trauma. 
Classification  of  ODRI: 
Device  related  infections  can  be  classified  as  defined  by  the  
“Centres  for  disease  Control  and  Prevention”  into  three  categories  based  
on  duration  and  timing  of  appearance  of  symptoms  post  surgery 
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1) Early  post  operative  infection:  These  occur  in  the  immediate  post  
operative  period  within  2  to  4  weeks.  It  is  caused  by  virulent  
organisms  like  Staphylococcus  aureus  and  E  coli. 
2) Late/chronic  infection:  Manifestation  of  infection  occurs  after  1  
month  of  surgery.  Mostly  they  are  organisms  of  low  virulence  for  
example  CoNS  (Coagulative  negative  staphylococcus  species),  
Propionibacterium  acne. 
3) Haematogenous  infection:  Manifestation  of  infection  occurs  after  
2  years  of  surgery.  Haematogenous  seeding  may  be  triggered  by  
skin,  dental,  respiratory,  and  urinary  tract  infections.     
Sources  of  infectious  pathogens[9]  which  facilitates  device  related  
infections  include  environment  of  the  operating  room,  surgical  equipments,  
clothing  worn  by  medical  and  paramedical  staffs,  resident  bacterial  flora  
on  the  patients  skin  etc. 
Bacteria  exists  in  two  forms:  free  floating(planktonic)  and  surface  
associated(biofilm)[12].  Implant  associated  infection  are  the  result  of  
bacterial  adhesion  to  an  implant  surface  and  subsequent  biofilm  formation  
at  the  implant  site.  Biofilms  mainly  confer  resistance  to  many  antibiotics  
and  impair  host  immune  response.  As  a  result  standard  antibiotic  therapy  
mainly  reverses  signs  and  symptoms  caused  by  planktonic  bacteria  released  
from  biofilm  but  fail  to  kill  bacteria  in  the  biofilm.   
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So  once  frank  implant  associated  infection  develops,  the  
management  becomes  difficult  and  comprises  mainly  of  repeated  surgical  
debridement  at  frequent  intervals.  It  is  not  only  a  physical  ailment  for  
the  patient  but  also  adds  to  his  psychological  and  financial  load. 
Following  are  the  bacterial  pathogens  encountered  in  the  orthopaedic  
implant  infections[11].  Staphylococcus  aureus  is  the  most  frequently  
isolated  organism  followed  by  Klebsiella  spp,  Pseudomonas  aeroginosa,  
Proteus  spp,  and  also  polymicrobial.  About  50  to  60%  of  these  infections  
develop  within  1  month  of  surgery,  30  to  40%  develop  within  2yrs,  and  
the  remainder  develop  more  than  2yrs  after  surgery. 
Each  hospital  has  its  own  unique  bacterial  flora  to  which  patients  
are  at  risk  for  acquiring  infection  during  hospitalization.  In  such  situations  
microorganisms  exhibit  unique  pattern  of  antibacterial  activity  during  a  
certain  period.  Since  initial  antibiotic  therapy  is  empirical  it  is  important  
to  know  the  prevailing  antibiotic  susceptibility  pattern  of  individuals  by  
routine  surveillance.  Hence  a  regular  bacteriological  review  of  infected  
implants  are  therefore  necessary  if  affected  patients  are  to  receive  quality  
health  care. 
Infections  associated  with  implants  represent  one  of  the  most  
devastating  complications  associated  with  high  morbidity  and  substantial  
cost.  In  the  recent  years  the  organisms  isolated  from  these  infected  cases  
are  showing  increased  resistance  to  commonly  used  first  line  antibiotics  
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and  multidrug  resistance.  So  early  detection  of  implant  infection  is  
therefore  crucial.  The  advantage  of  which  include  timely  administration  
of  antibiotic  prophylaxis,  strict  infection  control  practices,  and  formulating  
an  effective  antibiotic  policy  to  prevent  and  treat  ODRI  in  patients,  and  
thereby  reduce  the  spread  of  antibiotic  resistant  strains  so  as  to  improve  
the  clinical  outcome  among  the  patients.     
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AIM  AND  OBJECTIVES 
AIM: 
 To  study  and  characterise  the  bacterial  pathogens  and  their  current  
antibiotic  susceptibility/resistance  pattern  in  patients  with  orthopaedic  
implant  associated  infections. 
OBJECTIVES: 
1) To  isolate  and  identify  the  bacterial  pathogens  in  patients  with  
orthopaedic  implant  associated  infections. 
2) To  assess  the  antibiotic  susceptibility  pattern  of  microbial  isolates. 
3) To  determine  the  resistance  pattern  among  the  isolates. 
4) Genotyping  of  the  resistant  strains. 
5) To  formulate  antibiotic  policies  and  proper  infection  control  
measures  with  reference  to  implant  associated  infections  in  our  
hospital.   
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REVIEW  OF  LITERATURE 
Hall  marks  in  the  history  of  orthopaedic  implants  for  trauma  and  
joint  replacement. 
Nowadays  implant  surgery  has  become  one  of  the  commonest  
sugery,  because  of  the  success  of  this  procedure  in  restoring  function  to  
the  affected  bone  and  joint.  In  this  historical  review,  an  attempt  was  
made  to  present  the  evolution  of  orthopaedic  implants  for  trauma  and  
arthroplasty  during  the  20th  century. 
Trauma,  the  early  era 
It  was  during  the  1860s,  that  the  first  aseptic  surgical  technique  
had  been  described  by  the  British  Surgeon  Joseph  Lister(1827-1912).  At  
the  beginning  of  the  20th  century  attempts  to  use  implants  in  orthopaedic  
surgery  were  still  scarce  and  relatively  rare  as  medical  community  had  
not  been  persuaded  for  the  use  of  artificial  parts,  metallic  or  non  metallic. 
The  first  attempts  were  related  to  the  reconstruction  of  fracture  of  
long  bones  and  their  joints.  Sir  William  Arbuthnot  Lane(1856-1943),  
British  Surgeon  together  with  orthopaedic  nurse  British  Dame  Agnes  
Gwendoline  Hunt(1866-1948)  and  Belgian  surgeon  Albin  Lambotte(1866-
1955)  designed  a  fracture  plate  made  of  stainless  steel. 
The  post  Lister  era,  was  marked  by  the  fact  that  implants  and  
biomaterials  could  not  be  correlated  to  success  or  failure  of  prosthetics  
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and  it  was  a  common  practice  to  remove  an  implant  soon  after  its  original  
purpose  of  use  was  achieved.  Even  though  newer  materials  were  
manufactured,  the  use  of  stainless  steel  remained  extensive.  Martin  
Kirschner  (1879-1942)  a  German  surgeon,  used  pins  and  wire  to  reinforce  
the  connection  of  the  implant  to  the  bone,  a  method  that  carries  his  name  
ever  since,  K-wire  or  Kirschner  wire.   
Surgical  treatment  of  the  fracture  of  the  femoral  neck  was  the  next  
achievement  in  implant  surgery.  During  1926,Ernest  William  Hey  
Groves(1872-1944)  first  used  common  carpentry  screws,  which  was  later  
replaced  by  Vitallium. 
The  intramedullary  nailing  was  the  field  for  research  by  Ernest  
Hay  Groves,  He  was  the  one  who  used  metallic  rods  first.  He  had  noticed  
that  the  fracture  healed  without  the  use  of  plaster  or  a  traction  device,  
and  it  was  a  breakthrough  in  the  history  of  Orthopaedics. 
External  fixation  methods  were  also  developed,  in  the  U.S.  Clayton  
Parkhill(1860-1902)  from  Denver,  had  presented  a  paper  on  external  
fixation  device  to  the  American  College  of  Surgeons  in  1897  and  his  
method  was  extremely  popular  during  the  1st  World  War. 
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Trauma  in  the  post  war  era   
In  the  years  that  followed  2nd  World  War,  Orthopaedic  Surgeons  
tried  to  perfect  the  methods  of  fracture  fixation  mainly  by  using  wires  
and  pins  as  developed  by  German  Surgeon  Martin  Kirschner(1879-1942).  
A  new  boost  was  given  by  the  advent  of  antibiotics,  a  fact  that  made  
possible  prolonged  operations  with  a  reduced  risk  for  infection.   
Nowadays  external  fixation  is  still  in  use  for  the  treatment  of  
fractures  with  significant  soft  tissue  damage  for  immobilization  of  pelvic  
and  long  bone  fractures  especially  in  multi  trauma  patients.  Disadvantages  
were  considered  to  be  limited  joint  flexion  ,  the  increased  risk  of  non-
union  and  the  infection  in  the  pin  entry  sites  (10%  of  cases).On  the  other  
hand,  replacing  an  external  fixator  with  an  intramedullay  nail,  also  
increases  the  risk  of  infection. 
The  introduction  of  antibiotics  was  a  major  step  in  the  treatment  
of  infections.  Alexander  Fleming  in  1928  made  a  discovery  that  the  
fungus  Penicillum  produced  a  substance  that  could  destroy  staphylococcus. 
The  active  microbial  substance  was  used  clinically  by  Howard  
Foley  in  1940  to  treat  a  severe  mixed  infection  with  staphylococcus  
aureus  and  streptococci  in  Oxford.  Penicillin  was  rapidly  introduced  in  
clinical  practice  followed  by  streptomycin  in  1944  and  other  numerous  
antibiotics. 
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John  Burke  published  his  study  about  the  timing  of  
chemoprophylaxis.  During  his  study  he  observed  that  antibiotics  given  
systemically  were  effective  against  staphylococcal  strains,  only  if  present  
within  short  period  of  incision.  These  data  led  to  universal  agreement  
that  adequate  systemic  antibiotics  need  to  be  present  in  the  immediate  
pre  incision  period  to  ensure  maximum  effectiveness. 
  Trauma,  biological  osteosynthesis  and  contempory  developments 
During  the  modern  era  1990,  new  systems  made  of  bioabsorbable  
non-metallic  materials  became  popular.  The  greatest  advantage  of  these  
implants  was  that  they  are  progressively  absorbed  and  do  not  remain  in  
situ  like  those  that  are  metallic  ,  and  therefore  a  second  operation  for  
the  removal  of  materials  after  the  fracture  healing  is  avoided.   
Definition:   
Orthopaedic  implants  can  be  defined[1]as  medical  devices  used  to  
replace  or  provide  fixation  of  bone  or  to  replace  articulating  surface  of  
a  joint.  In  simpler  words,  orthopaedic  implants  are  used  to  either  assist  
or  replace  damaged  or  troubled  bones  and  joints.  Orthopaedic  implants  
are  mainly  made  of  stainless  steel  and  titanium  alloys  for  strength  and  
lined  with  plastic  to  act  as  artificial  cartilage  in  order  to  reduce  the  stress  
at  the  articulating  surfaces. 
Some  examples  of  orthopaedic  implants[1]are  orthopaedic  plates,  
orthopaedic  nails,  orthopaedic  screws.  The  key  factor  that  guides  bone  
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healing  is  the  interfragmentary  movement,  which  determines  the  tissue  
strain  and  consequently  the  cellular  reaction  in  the  fracture  healing  zone. 
Classification  of  orthopaedic  fixation  devices.[1] 
1) Internal  fixation  devices: 
Screws,  plates,  wires  and  pins,  intramedullary  rods  &  nails,  and  spinal  
fixation  devices. 
2)  External  fixation  devices:   
a)  Fracture  fixation  devices-  Radius,Tibia,Pelvis.  b)  Bone  lengthening-  
IIizarov  device. 
Incidence  and  prevalence  of  ODRI 
Orthopaedic  and  trauma  device-related  infection(ODRI)  remains  a  major  
complication  in  modern  trauma  and  orthopaedic  surgery.  The  global  
incidence  of  ODRI  remains  approximately  1%  after  primary  and  3%  to4%  
after  revision  surgery.   
Lakshminarayana.S.A,et  al.,in  2015  reported  an  incidence  rate  of  
implant  infection  varying  from0.5%to2%  in  fixation  of  closed  fractures  to  
30%  after  fixation  of  open  fractures.  This  variation  was  due  to  the  
differences  in  clinical  procedures,  types  of  organisms,  resistance  pattern  
of  the  organisms,  control  measures,  and  hospital  environment. 
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Muhammad  Shoaib  Khan  et  al.,  (2007)  in  his  study  reported  the  
rate  of  infection  as  5.76%  which  was  higher  than  the  accepted  standard  
which  should  be  <1%  and  this  was  due  to  predisposing  factors  like  
advanced  age,  prolonged  surgery  time,  smoking,  and  skin  abrasion. 
Prathab  et  al.,  in  (2015)  study  had  showed  culture  positivity  of  
73%  which  is  less  when  compared  to  other  studies  whereas  Anisha  
Fernandez  et  al  reported  84%,  and  Khosravi  et  al,  and  Vishwajith  et  al,  
reported  the  culture  positivity  of  93%  and  94%  respectively.  Gomez  et  
al,  reported  even  lesser  positivity  of  60%. 
Ravikanth  et  al,  in  2015,  found  out  the  rate  of  implant  infection  
was  12%,  as  compared  to  study  by  Maksimovic  et  al,  which  showed  an  
infection  rate  of  22%  which  is  much  higher 
In  a  study  of  165  patients  by  Khosravi  et  al,  (2009),  the  incidence  
of  implant  infection  in  open  and  external  fractures,was  17.6%,  and  82.4%  
of  implant  infections  occurred  in  closed  and  internal  fractures. 
Risk  factors 
Major  risk  factor  for  development  of  implant  associated  infection  
depends  upon  the  extent  of  damage  to  the  soft  tissue  and  periosteum  
following  fracture.  Devascularised  bone  and  other  necrotic  tissue  are  ideal  
for  multiplication  of  bacteria.  Damage  to  the  periosteal  blood  supply  and  
lack  of  perfusion  of  the  soft  tissues  not  only  interfere  with  fracture  
healing  and  but  also  prevent  humoral  and  immunological  host  defence  
14 
 
mechanisms  from  reaching  the  traumatised  area,  and  fighting  the  spread  
and  multiplication  of  inoculated  microorganisms  at  the  bone-  implant  
interface.   
The  type  of  fracture  whether  it  is  open  or  closed  fracture,  type  of  
implant  used,  type  of  surgery  whether  emergency  or  elective  procedure,  
choice  of  antibiotic  prophylaxis,  duration  of  surgery,  type  of  anaesthesia,  
duration  of  hospital  stay,  all  these  factors  influence  the  risk  of  developing  
implant  infections. 
In  a  prospective  study  of  63  patients  by  Prathab  et  al  (2015)  the  
most  common  co  morbid  condition/risk  factor  associated  with  ODRI  was  
found  to  be  old  age,  followed  by  Diabetes  mellitus,  and  H1N1  in  5  cases. 
A  six  years  of  study  by  Dabet  Rynga  et  al  (2016),  observed  that  
the  most  probable  sources  of  infection  were  from  the  stretchers,  the  stands  
for  intravenous  solutions,  the  OT  table,  instrument  trolley,  X-ray  machine,  
suction  cannula  tip.  The  other  sources  of  infection  are  also  described  by  
Aggarwal  et  al,  who  observed  that  the  source  of  infection  was  most  
probably  the  gut  flora,  which  in  the  prolonged  bed  ridden  patients  can  
contaminate  their  surroundings. 
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Patient  related  risk  factor:   
Age:  The  risk  of  ODRI  is  found  to  be  higher  in  older  patients.  In  
comparision  to  younger  population  these  patients  are  usually  characterised  
by  impaired  immune  response  to  infectious  agents,  inferior  nutritional  
status,  and  possibly  more  co-morbidity.   
Co-morbid  conditions:  it  is  well  established  that  in  patients  undergoing  
surgery  Diabetes  mellitus  is  associated  with  increased  risk  for  
complications  and  increased  length  of  hospital  stay.  In  general  
hyperglycaemia  may  cause  distruption  of  the  host  response  to  a  bacterial  
load. 
Connective  tissue  disorders:  Connective  tissue  disease  has  been  correlated  
with  increased  risk  of  ODRI.  This  group  of  conditions  including  
Rheumatoid  arthritis,  Systemic  lupus  erythematosis,  Psoriatic  arthritis  is  
associated  with  immune  modulation  resulting  in  predisposition  to  infection.  
More  over  patients  on  chronic  immunosuppressive  and    glucocorticoid  
treatment  has  been  identified  as  a  risk  factor  for  infection  following  
implant  surgery.  Novel  biologic  agents  (TNF  α  blockers)used  in  the  
treatment  many  of  these  conditions  are  known  to  adversely  affect  the  
patient’s  ability  to  fight  infection  are  additional  risk  factors. 
Malignancy:  The  presence  of  malignancy  has  been  confirmed  to  increase  
ODRI.  It  might  be  due  to  the  potential  effects  of  malignancy  associated  
treatment  such  as  glucocorticoids  and  cytotoxic  agents. 
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Other  conditions  include  preoperative  anaemia,  liver  disease,  chronic  
kidney  disease,  previous  myocardial  infarction,  congestive  heart  failure,  
pulmonary  diseases,  concurrent  urinary  tract  infection,  cigarette  smoking,  
alcohol  abuse  etc. 
Pathogenesis  and  clinical  presentation  of  implant  infections 
A  fundamental  concept  in  the  pathogenesis  of  ODRI  is  the  
formation  of  biofilms  by  the  infecting  organism.  An  understanding  of  
pathogenesis  of  biofilm  formation  facilitates  optimal  diagnosis  and  
treatment.  All  implants  undergo  physiological  changes  after  implantation.  
The  earliest  and  clinically  the  most  important  step  is  the  “race  for  the  
surface”,  a  contest  between  tissue  cell  integration  and  bacterial  adhesion  
to  the  same  surface[11]. 
Biofilm                       
Biofilm  is  a  colony  of  microorganisms  suspended  within  a  self  
produced  matrix,  the  extracellular  polymeric  substance.  Estimates  report  
that    99%  of  bacteria  can  exist  within  a  biofilm  state.  The  common  
organisms  responsible  for  biofilm  associated  infection  include  
Staphylococcus  aureus,  Staphylococcus  epidermidis,  and  Pseudomonas  
aeroginosa.[13] 
Biofilm  formation 
The   adhesion   of   a  planktonic  bacterium  to  an  inert  surface  leads  
to  the  formation  of  a  biofilm  in  phases:  
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adhesion→aggregation→mutation→dispersal.  The  process  depends  upon  
local  conditions  such  as  hydrophobicity  and  acidity,  oxygen  concentration,  
presence  of  inert  material  and  the  ability  of  the  bacterium  to  initiate  
contact  via  pili/flagella. 
Biofilm  function 
The  ultimate  function  is  to  create  a  protective  environment  within  
which  bacteria  can  sustain  a  state  of  existence  without  overwhelming  the  
host.  Secretion  of  virulence  factors  conveys  a  unique  environment  for  the  
bacteria  to  continue  to  evolve  and  mature  allowing  evasion  of  innate  and  
adaptive  immune  responses  and  development  of    tolerance  to  antimicrobial  
agents. 
Clinical  presentation:   
Infections  associated  with  ‘internal  fixation  devices’  is  multifaceted  
[12]  and  depends  on  1)the  preceding  trauma  or  surgical  procedures,  2)the  
anatomical  localization,  3)the  quality  of  bone  and  surrounding  soft  tissue,  
4)the  interval  between  microbial  inoculation  and  manifestation  of  infection  
and5)the  type  of  organism. 
Most  infections  associated  with  internal  fixation  devices  are  acquired  
exogenously,  typically  in  the  post  operative  period.  Early  post  operative  
infection  (<3weeks)  is  characterized  by  erythema,  local  hyperthermia,  
protracted  wound  healing  and  a  secreting  wet  wound.  Thus  wound  healing  
disturbances  after  internal  fixation  are  highly  suspicious  of  early  infection  
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and  should  be  managed  as  such.  The  first  step  is  always  debridement  
surgery  for  diagnostic  and  therapeutic  purposes.   
Delayed  (3-10  weeks)  or  chronic  (>10  weeks)  infections  are  
typically  due  to  low  virulence  microorganisms  such  as  coagulase-negative  
staphylococci  or  result  from  inadequate  treatment  of  early  infection.  
Delayed  or  chronic  infections  manifest  as  persistant  pain,  or  signs  of  local  
inflammation  such  as  erythema,  swelling  or  intermittent  drainage  of  pus.  
Radiologically  delayed  consolidation,  pseudarthrosis,  bone  sequesters  and  
soft  tissue  calcification  can  be  observed. 
‘External  fixation’  is  a  surgical  treatment  used  to  stabilize  bone  
and  soft  tissues  at  a  distance  from  the  operative  or  injury  site.  With  
external  fixation  pins  are  inserted  through  the  skin  into  the  bone  and  held  
in  place  by  an  external  frame.  The  usual  indications  are  open  fractures  
such  as  tibia  fracture  which  requires  dressings  or  attention  to  a  wound  
or  flap.  Without  proper  technique  for  pin  insertion  and  meticulous  pin  
tract  care,  this  may  result  in  pin  sepsis,  occurring  in  30%  of  patients.  It  
varies  from  minor  inflammation  to  superficial  infection  requiring  
antibiotics,  local  wound  care,  and  occasional  pin  removal  ,  to  osteomyelitis  
requiring  sequestrectomy. 
 
 
Causes  of  pin  sepsis  are:[13] 
19 
 
1)Site  selection:  the  more  the  soft  tissue  is  there  ,  the  greater  is  the  
chance  of  sepsis 
2)Skin  tethering:  close  wounds,  if  possible  before  inserting  the  pin,  as  
closure  will  be   
to  relieve  skin  tension. 
3)Use  of  power  instruments:  drilling  wide  diameter  pins  directly  into  the  
bone  will  generate  heat,  this  may  lead  to  sequestrum  formation  and  sepsis. 
4)Pin  care:  inadequate  pin  care  and  poor  hygiene  may  lead  to  sepsis.   
Novel  classification  of  periprosthetic  joint  infection(PJI)  [12] 
Type  of  PJI Characteristics 
1)Acute  haematogenous 
 
2)Early  postinterventional 
 
3)Chronic 
-Infection  with  a  duration  of  symptoms  of  3  
weeks  or  less  after  an  uneventful  post  
operative  period 
-Infection  that  manifests  within  1  month  after  
an  invasive  procedure  such  as  surgery  or  
arthocentesis 
-Infection  with  symptoms  that  persists  for  
more  than  3  weeks,  beyond  the  early  post  
interventional  period 
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Diagnosis  of  implant  infections[5] 
A  combination  of  clinical,  laboratory,  histopathology,  microbiology  
and  imaging  studies  are  required  for  the  diagnosis  of  implant  infection.   
Early  infection  is  usually  easy  to  diagnose,  as  it  present’s  clinically  
with  both  local  and  systemic  signs.  There  may  be  erythema,  edema,  
induration,  raised  temperature  or  even  frank  pus  discharge  at  the  operative  
site.  Systemic  signs  include  fever,  malaise,  lethargy,  and  loss  of  appetite.  
Secretory  wet  wounds  and  unsatisfactory  wound  healing  are  common  
presentations.   
In  case  of  delayed  and  late  infections,  a  high  degree  of  suspicion  
is  required.  Delayed  or  chronic  infection  may  present  as  persistent  pain  
at  local  site,  local  signs  of  inflammation  or  sinus.  It  is  often  seen  that  
sinuses/discharge  from  interlock  screw/bolts  or  persisting  discharging  sinus  
in  a  plated  fracture.  Unusual  delay  in  fracture  healing,  loosening  of  plates  
and  screws  should  be  taken  as  highly  suspicious  in  favour  of  infection  
even  if  there  may  not  be  exterior  signs  of  infection. 
Radiography: 
1)  Plain  X-ray  of  the  operative  site  may  not  contribute  to  the  
diagnosis  in  the  initial  post  operative  days.  If  infection  is  suspected  
clinically,  even  in  the  absence  of  radiological  signs  of  infection  ,  it  is  
wiser  to  explore  the  wound  and  send  the  material  for  histology,  culture  
and  sensitivity. 
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2)  Contrast  arthrography  improves  accuracy  of  assessing  implant  
stability.  Synovial  outpouchings  and  abscesses  are  typical  signs  of  
infection.[4] 
Ultrasonogram:   
Ultrasonography  may  detect  fluid  effusions  around  the  prosthesis  
and  can  be  used  to  guide  joint  aspiration  and  drainage  procedures.[4] 
  Nuclear  medicine:  Scintigraphy  by  means  of  a  technetium(Tc99m)  scan,  
Galium  citrate(Ga67),  or  indium(In111)-labelled  leukocyte  scan  may  be  
helpful  in  the  diagnosis  of  ODRI.  However  this  approach  is  expensive,  
and  accuracy  of  these  methods  is  still  limited.[5]:   
Haematology: 
Blood  leukocyte  counts  and  differential  counts  may  show  
leukocytosis  and  neutrophilia  in  acutely  acquired  infections.  Post  surgery,  
C-  Reactive  protein  and  ESR  is  acutely  elevated  and  returns  to  normal  
within  weeks.  Therefore  preoperative  and  repetitive  postoperative  values  
are  more  informative  than  a  single  value  in  the  post    period.  In  prosthetic  
knee  infections  synovial  fluid  leukocyte  count  of  more  than  1.7  x  109/l  
and  differential  of  more  than  65%  neutrophils  has  a  sensitivity  for  
infection  of  94%  and  97%  and  specificity  of  88%  and  98%  respectively.[5] 
Histopathology:   
Histopathological  examination  of  the  periprosthetic  tissue  has  a  
sensitivity  of  more  than  80%  and  a  specificity  of  more  than  90%.  
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Histopathology  examination  does  not  identify  the  causative  organism  but  
it  can  confirm  the  presence  of  infection.   
Sonication:   
New  diagnostic  approaches  include  sonication  of  removed  implants  
to  dislodge  adherent  microorganisms  growing  in  biofilms  and  the  use  of  
molecular  techniques  to  improve  diagnostic  yield.[5]   
Bacterial  pathogens  in  implant  infections   
The  following  are  the  organisms  isolated  from  orthopaedic  implant  
infections.  Staphylococcus  aureus  is  the  most  common  organism,  followed  
by  Klebsiella  spp,  Pseudomonas  aeruginosa,  Proteus  spp,  Coagulative  
negative  Staphylococcus,  Escherichia  coli,  Acinetobacter  spp,  and  
Enterococcus  fecalis  . 
Staphylococcal  infections:   
Staphylococcus  aureus  is  the  most  virulent  organism  among  the  
Staphylococcus  species  and  remains  a  major  cause  of  infection  in  implants.  
It  is  a  pluripotent  pathogen  causing  disease  by  both  toxin  mediated  and  
non  toxin  mediated  mechanisms.  Staphylococcus  aureus  is  responsible  for  
not  only  implant  infections  but  also  causes  life  threatening  systemic  
infections.  The  less  virulent  Staphylococci-  Coagulase  negative  
staphylococci(CONS)  are  part  of  normal  skin  flora  but  act  as  opportunistic  
pathogens  occasionally.   
The  genus  Staphylococcus  belongs  to  family  Micrococcaceae  and  
contains  36  species.  It  is  an  aerobe  and  facultative  anaerobe,  non-motile,  
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Gram  positive  cocci  about  1µm  arranged  in  clusters,  pairs  and  tetrads.  
Staphylococcus  produce  catalase  and  ferments  many  sugars  and  forms  
lactic  acid  but  no  gas.  Each  strain  varies  by  its  proteolytic  activity  and  
they  produce  many  extracellular  substances.  Staphylococci  can  survive  in  
dried  items,  tolerate  heat(up  to  50°C  for  30  minutes)  and  9%  sodium  
chloride. 
Virulence  factors  of  staphylococcus  aureus: 
1)Peptidoglycan  and  teichoic  acids: 
The  cell  wall  of  Staphylococcus  aureus  contains  peptidoglycan  and  
teichoic  acid  a  unique  rebitol  phosphate  polymer.  The  main  function  of  
teichoic  acid  is  to  help  the  bacteria  to  adhere  to  mucosal  surface  and  
peptidoglycan  provide  rigidity  to  cell  wall  and  contributes  to  virulence  by  
activation  of  complement,  enhancement  of  chemotaxis  of  polymorph  
nuclear  cells  and  interlukin-1  production  by  monocytes. 
  Cell  surface  adhesions: 
  fibrinonectin  binding  proteins,  collagen  binding  proteins,  and  clumping  
factor. 
ll  )  Protein  A: 
Staphylococcus  aureus  cell  wall  contains  specialized  protein  on  its  
cell  surface  called  protein  A;  they  belong  to  group  of  adhesins  called  
microbial  surface  components  recognizing  adhesive  matrix  molecules  
(MSCRAMMS).  Protein  A  has  many  biological  properties,  such  as  
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anticomplimentry,  chemotactic,  mitogenic,  inhibition  of  opsonisation  and  
induction  of  platelet  damage.  It  mediates  co-agglutination  reaction.   
lll)  Capsular  polysaccharide: 
Some  strains  of  Staphylococcus  aureus  produce  exopolysaccharide  
that  prevents  them  from    ingestion  by  polymorphonuclear  cells  and  there  
are  11  types  of  capsular  polysaccharide. 
lV)  Enzymes: 
Many  enzymes  are  produced  by  Staphylococcus  aureus   
The  enzyme  catalase  produced  by  Staphylococcus  aureus  inactivates  
the  free  radicles  and  hydrogen  peroxide  and  helps  in  its  survival  in  the  
host.   
It  has  another  cell  bound  material  called  clumping  factor  which  
helps  in  binding  of  fibrin  and  fibrinogen  to  their  cell  wall  and  safeguards  
them. 
The  enzyme  coagulase  exists  in  free  and  bound  forms  which  bind  
to  prothrombin  then  becomes  active  and  converts  fibrinogen  to  fibrin  and  
this  fibrin  forms  a  coat  around  the  bacterial  cells  and  make  them  resistant  
to  opsonisation  and  phagocytosis.Tube  coagulase  test  has  specificity  of  
98.1%  and  sensitivity  of  98.7%.   
Enzyme  fibrinolysin  which  is  produced  by  Staphylococcus  acts  by  
breaking  the  fibrin  clots  and  enhances  the  spread  of  infection.   
Hyaluronidase  hydrolyses  the  intracellular  matrix  and  aids  in  the  
spread  of  organism  in  tissues.   
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Three  different  types  of  β-lactamase  enzymes  are  producd  by  
Staphylococcus  aureus  these  enzymes  may  be  inducible(i.e.,  produced  only  
in  the  presence  β  lactum  antibiotics)  or  constitutive(i.e.,  produced  
continuously),  genes  which  code  for  these  enzymes  are  found  on  plasmids.  
These  resistance  genes  may  be  transferred  to  other  bacteria  by  
transformation  and  transduction. 
V)  Haemolysins: 
Four  types  of  haemolysins  are  produced  by  Staphylococcus  .  α-  
hemolysin  is  a  heterogenous  protein,  acts  as  neurotoxin  by  causing  
demyelination  of  myelin  sheath  and  this  hemolysin  is  responsible  for  the  
hemolysis  observed  around  colonies  of  staphylococcus  aureus  grown  in  
sheep  blood  agar  .   
β  hemolysin  is  a  sphingomyelinase  which  acts  on  sphingomyelin  
present  in  many  cells  mainly  human  red  blood  cells,  it  is  also  known  as  
hot-cold  hemolysin. 
Delta  hemolysin  is  produced  by  more  than  97%  of  Staphylococcus  
aureus  strains  they  act  as  surfactants  and  damage  cell  membrane.   
γ  hemolysin  is  made  of  3  proteins  and  along  with  2  proteins  of  
Panton  valentine  leukocidin(PVL)  form  six  set  of  two  component  toxins,  
this  hemolysin  lyses  leukocytes  efficiently. 
  
26 
 
Vl)  Toxins: 
There  are  three  important  toxins  produced  by  Staphylococcus  aureus  
and  these  are  Exfoliative  toxin,  Toxic  shock  syndrome  toxin(TSST),  and  
Entero  toxin.  Each  toxin  has  got  different  action  on  different  tissues  or  
systems.  Exfoliative  toxin  cause  dermal  exfoliation.  TSST  is  responsible  
for  toxic  shock  syndrome.      Enterotoxins  are  heat  stable  and  are  
responsible  for  food  poisoning. 
Vll)Superantigens. 
The  Staphylococcal  enterotoxins  along  with  toxic  shock  syndrome  toxin  
are  collectively  called  pyrogenic  toxin  superantigens.   
1) They  act  on  variable  domain  (Vβ)  of  T  cell  receptor   
2) Do  not  require  antigen  presentation  by  macrophage 
3) Directly  stimulate  non  specific  T  cells 
4) Leads  to  massive  release  of  cytokines  and  polyclonal  B  cell  
activation  . 
Identification  tests: 
  l)  Morphology  in  culture  medias: 
Staphylococcus  aureus  grows  well  in  simple  media. 
Nutrient  agar:  in  nutrient  agar  it  appears  as  smooth,  low  convex,  
glistening,  densely  opaque.  The  pigment  formation  in  nutrient  agar  when  
kept  in  room  temperature  in  aerobic  atmosphere  ranges  from  cream  colour  
to  golden  yellow  due  to  presence  of  carotenoids. 
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ll)  Biochemical  characters: 
Staphylococcus  aureus  produces  catalase,  ferments  10%  mannitol  to  
acid  and  10%  trehalose  to  acid.  It  liquefies  gelatine  by  enzyme  gelatinase,  
produce  deoxyribonuclease(D  Nase),  produce  heat  stable  thermonuclease(T  
Nase)  when  grown  in  toluidine  blue  DNA  agar  producing  a  pink  halo  
around  the  well.  Indole    negative,  but  urease  is  produced  and  gives  
positive  reaction  when  grown  in  Christensen’s  urea  medium.   
The  single  most  reliable  test  for  identification  of  Staphylococcus  
aureus  is  the  coagulase  test.  There  are  two  types  of  tests,  one  is  Slide  
coagulase  test  that  detects  bound  coagulase(clumping  factor)  present  in  S  
aureus  and  absent  in  most  other  Staphylococcus  species.  The  other  one  
is  Tube  coagulase  test,  that  detects  the  presence  of  free  coagulase  which  
reacts  with  clot  retracting  factor(CRF)  present  in  plasma,  which  in  turn  
reacts  with  fibrinogen  to  form  fibrin. 
lll)  Rapidec  Staph:   
It  is  a  rapid  kit  test  which  detects  the  presence  of  enzyme  aurease  
specific  to  coagulase  positive  Staphylococci,  the  enzyme  aurease  reacts  
with  prothrombin  to  form  a  complex  that  lyses  the  substrate  to  release  a  
flurogen  which  is  detected  by  its  fluorescence  under  ultraviolet  radiation  
at  365  nm.  Staphylococcus  is  identified  within  2  hours  with  the  help  of  
this  kit  method  and  also  identifies  MRSA  strains  that  are  not  detected  by  
conventional  tests. 
Klebsiella: 
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Klebsiella  species  are  usually  found  as  commensals  in  human  
intestines  and  as  saprophytes  in  soil.  K.pneumoniae  has  three  sub  species:  
K.  Pneumonia  subspecies  pneumoniae  :  It  is  the  most  pathogenic  and  
common  among  all  and  it  is  responsible  for  pyogenic  infections  such  as  
abscesses  and  wound  infections  .It  frequently  colonizes  the  oropharynx  of  
hospitalized  patients  and  is  a  common  cause  of  nosocomial  infections.  
Most  of  the  hospital  strains  are  multidrug  resistant.   
Biochemical  properties: 
Gram  staining:  Klebsiella  is  short,  plump,  straight  gram-negative  rods,  
about  1-2  µm  X  0.5-o.8µm  in  size 
Culture:  On  MacConkey  agar,  it  produces  large,  dome  shaped,  mucoid,  
sticky,  pink  colour  lactose  fermenting  colonies. 
Biochemical  identification  of  Klebsiella: 
Klebsiella  species  can  be  identified  by  the  following  properties. 
ICUT  test: 
Indole  test:  Negative 
Citrate  test:  Positive(citrate  is  utilized) 
Urease  test:Positive(urea  is  hydrolysed) 
TSI(triple  sugar  iron  agar  test):  Shows  acid/acid,  with  gas  formation,  H2S  
absent. 
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Sugar  fermentation  test: 
Ferments  most  of  the  sugars  such  as  glucose,  lactose,  mannitol,  
maltose(but  not  sucrose)  with  production  of  acid  and  gas 
VP(Vogas-  Proskauer)  test:  Postive 
MR(methyl  red)  test:  Negative 
Antigenic  Structure 
1.Capsular  (K)  Antigen 
On  the  basis  of  capsular  (K)  antigens,  the  Klebsiellae  have  been  
classified  into  80(1-80)  serotypes.  Identification  of  these  capsular  antigens  
is  usually  done  by  capsular  swelling  reaction  with  specific  capsular  
antiserum. 
2.Somatic  (O)  antigen 
Klebsiella  contain  five  (01-05)  different  somatic  or  O  antigens  in  
various  combinations.  Four  of  these  (01,  03,  04,  05)  are  identical  or  
closely  related  to  O  antigens  of  E  Coli. 
Methods  of  typing   
Phage  typing,  biotyping,  bacteriocin  typing(klebocin  or  pneumocin)  
and  resisto  typing  have  been  tried.  Many  Klebsiella  strains  produce  
bacteriocins  known  as  klebocins  or  pneumocins  which  show  a  narrow  
range  of  activity  on  other  Klebsiella  strains.  Klebocin  typing  can  be  done  
by  the  help  of  liquid  preparations  of  bacteriocins.  Klebocin  typing  and  
capsular  serotyping  together  may  be  very  useful  for  epidemiological  
studies. 
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Pseudomonas  aeruginosa: 
The  genus  Pseudomonas  comprise  of  aerobic,  Gram  negative,  non-  
fermentative,  non-sporing,  oxidase  positive  bacilli  which  are  motile  by  
polar  flagella.  Many  species  produce  water  soluble  pigments  which  diffuse  
through  the  culture  medium.  Majority  of  them  are  saprophytic  being  found  
in  soil,  water,  sewage,  or  wherever  decomposing  organic  matter  is  found. 
1) Culture 
It  is  a  strict  aerobe,  and  grows  well  on  ordinary  media  like  nutrient  
broth  and  nutrient  agar.  The  optimum  temperature  for  growth  is  
37ºC. 
a) Nutrient  agar:  Colonies  are  smooth,  large,  translucent,  low  convex,  
2-4  mm  in  diameter.  The  organism  produces  a  sweetish  aromatic  
odour.  There  is  greenish  blue  pigment  which  diffuses  into  the  
medium. 
b) Blood  agar:Colony  characters  are  similar  to  those  on  nutrient  agar.  
Many  strains  are  haemolytic  on  blood  agar. 
c) MacConkey  agar:  Colonies  are  pale  or  colourless(non-lactose  
fermenters) 
d) Cetrimide  agar:  It  is  a  selective  medium  for  Ps.  aeruginosa. 
e) Peptone  water:  It  forms  a  turbidity  with  surface  pellicle  since  it  
is  a  strict  aerobe. 
3.Pigment  production     
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Ps.Aeruginosa  produces  a  number  of  pigments  which  diffuse  into  
surrounding  medium.  These  pigments  are 1)Pyocyanin,  2)Pyoverdin,  
3)Pyorubin,  4)Pyomelanin. 
4.Biochemical  reactions 
Ps.  Aeruginosa  is  a  non-fermentor,  derives  energy  from  
carbohydrates  by  oxidative  breakdown.  .It  utilises  only  glucose  oxidatively  
with  acid  production.  Lactose  and  maltose  are  not  utilised.  They  are  
catalase,  oxidase,  and  citrate  positive.  Indole,  MR,  VP,  and  H2S  tests  
negative.  They  reduce  nitrates  to  nitrites.   
5)Resistance 
It  is  killed  by  heating  at  55◦C  for  1  hr.  It  is  resistant  to  chemical  
disinfectants  and  can  even  grow  in  certain  antiseptics  like  quaternary  
ammonium  compounds,  chloroxylenol  and  hexachlorophene.  It  is  
intrinsically  resistant  to  commonly  used  antibiotics.  Examples  of  clinically  
effective  antibiotics  are  polymyxin  B,  colistin,  piperacillin,  tricarcillin,  
cefotaxime,  gentamycin,  azlocillin,  tobramycin,  and  ciprofloxin. 
6)Antigenic  structure 
O  Antigens:  It  possesses  19  distinct  group  specific  O  antigens,  and  
they  are  heat  stable. 
H  antigens:  Two  heat  labile  H  antigens  have  been  recognised  in  
Ps.  aeruginosa. 
7)Toxins  and  Enzymes 
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Several  toxins  and  enzymes  produced  by  Ps.  aeruginosa  contribute  
to  enhance  its  virulence 
a)Exracellular  products:  pyocyanin  inhibits  mitochondrial  enzymes  in  
mammalian  tissue  and  causes  disruption  and  cessation  of  ciliary  beat  on  
ciliated  nasal  epithelium. 
b)Extracellular  enzymes  and  Haemolysins:  it  produces  proteases,  
haemolysins,  and  lipase.  These  play  a  key  role  in  producing  local  lesions. 
c)Exotoxins:  it  produces  two  exotoxins  A  and  S.  Exotoxin  A  is  a  
polypeptide.  It  inhibits  protein  synthesis,  its  mechanism  of  action  is  similar  
to  that  of  diphtheria  toxin. 
d)  Endotoxins:  it  is  a  lipopolysaccharide(LPS),  exhibiting  many  biological  
properties  of  enterobacterial  LPS  including  pyrogenic  action. 
8)Typing  methods 
As  Ps.aeruginosa  ia  an  important  cause  for  hospital  acquired  infections,  
it  is  essential  to  type  the  strain  for  epidemiological  study. 
a) Bacteriocin(pyocin)  typing:  three  types  of  pyocins  are  produced  by  
Ps.  aeruginosa.  These  pyocins  are  known  as  R,  F  and  S.  Pyocin  –  
producing  strains  are  resistant  to  their  own  pyocins  though  they  
may  be  sensitive  to  pyocins  produced  by  other  strains. 
b) Phage  typing:  considerable  difficulties  have  been  encountered  in  
bacteriophage  typing. 
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c) Serotyping:  based  on  O  and  H  antigens,  17  serotypes  of  Ps.  
aeruginosa  are  recognised.  It  is  said  to  be  reliable  but  facilities  
exist  only  in  reference  laboratories. 
d) Molecular  method:  restriction  endonuclease  typing  with  pulsed  field  
gel  electrophoresis(PAGE)  is  the  most  reliable  typing  method 
Proteus 
These  are  motile,  Gram  negative  bacteria  characterised  by  swarming  
growth  on  agar.  They  were  named  Proteus  because  of  their  pleomorphic  
character,  after  the  Greek  God  Proteus  who  could  assume  any  shape. 
Morphology 
These  are  Gram  negative  bacilli  measuring  1-3  x  0.5µm  insize.  
They  are  non  capsulated,  non-sporing,  and  actively  motile.  They  possess  
peritrichate  flagella.  They  may  present  as  short  coccobacillary  forms,  long  
and  filamentous  type  especially  in  young  cultures. 
Culture   
They  are  aerobic  and  facultative  anaerobic.  They  grow  on  ordinary  
media  and  culture  emits  a  characteristic  putrefactive  (fishy  or  seminal)  
odour.  When  grown  on  nutrient  agar  or  blood  agar,  it  exhibits  swarming.  
Swarming  of  Proteus  appears  to  be  due  to  vigorous  motility  of  the  
bacteria.   
They  form  smooth,  pale,  or  colourless(NLF)  colonies  on  
MacConkey’s  agar  and  do  not  swarm  on  this  medium.  In  liquid  
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medium(peptone  water);  it  produces  uniform  turbidity  with  a  slight  
powdery  deposit  and  an  ammoniacal  odour. 
Dienes  Phenomenon   
When  two  different  strains  of  Proteus  species  are  inoculated  at  
different  places  of  the  same  culture  plate,  swarming  of  the  two  strains  
remain  separated  by  a  narrow,  visible  furrow.  However  in  case  of  two  
identical  strains  of  Proteus,  swarming  of  the  two  coalesce  without  signs  
of  demarcation.  It  is  known  as  Dienes  phenomenon.  It  has  been  used  to  
determine  the  identity  or  non-identity  of  different  strains  of  Proteus. 
Biochemical  Reactions 
The  distinctive  characters  of  this  genus  are:  1)  Deamination  of  
phenyl  alanine  to  phenyl  pyruvic  acid(PPA  test).  It  is  always  positive. 
2)Hydrolysis  of  the  urea  by  enzyme  urease-  it  is  another  characteristic  
of  Proteus 
3)They  ferment  glucose  by  producing  acid  and  gas.  Lactose  is  not  
fermented.  Indole  is  formed  by  Pr.  vulgaris,  but  is  negative  in  Pr.  
mirablis. 
4)  They  are  MR-  positive,  VP-negative 
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Antigenic  structure 
The  bacilli  possess  thermostable,  ‘O’(somatic)and  thermolabile  
‘H’(flagellar)  antigens,  based  upon  which  several  serotypes  have  been  
recognised.  Weil  and  Felix  noted  that  certain  non  motile  strains  of  Pr.  
vulgaris,  called  the  ‘X’  strains  were  agglutinated  by  sera  of  typhus  
patients.  The  sharing  of  polysaccharide  antigens  of  Proteus  with  some  
Rickettsiae  forms  the  basis  of  the  Weil  and  Felix  reaction  for  the  diagnosis  
of  some  rickettsial  infections.  These  non  motile  strains  of  Proteus  are  
employed  as  the  antigens  for  this  test-Pr.  vulgaris  strains  OX  2,  OX  19,  
and  Pr.  mirablis  OX  K. 
Treatment  strategies  (4,5,7,11) 
The  ultimate  goal  of  a  successful  therapy  is  a  long  term  pain-free  
and  functional  joint  and  limb.  Eradication  of  an  orthopaedic  device  related  
infection  is  best  achieved  by  combination  of  both,  an  appropriate  surgical  
procedure  and  a  prolonged  antimicrobial  treatment. 
The  surgical  treatment  strategies  include: 
a)If  the  duration  of  symptoms  are<3  weeks,stable  implants,absence  
of  sinus  tract  and  susceptibility  to  antibiotics  with  activity  against  
surface-adhering  microorganisms,the  the  implants  can  be  retained  
and  only  debridement  can  be  done. 
b)If  an  implant  is  not  necessary  to  maintain  bony  stability,  it  should  
be  removed. 
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c)  Implants  needed  for  stability  should  be  retained  until  there  is  
bony  stability,  or  they  should  be  replaced  by  another  form  of  
fixation(e.g.,  removing  a  plate  and  replacing  it  with  an  external  
fixator). 
d)If  infections  are  not  treated  aggressively  ,  surgical  fixation  can  
be  compromised.  It  is  easier  to  treat  a  stable  healed  fracture  with  
osteomyelitis  than  an  unstable  infected  non-union  fractures. 
Infected  implants  can  be  removed  by 
i)The  traditional  One-  stage  exchange  includes  the  removal  and  
implantation  of  a  new  prosthesis  during  the  same  surgical  procedure,  and  
has  a  success  rate  of  86%  to  100%  in  appropriately  selected  patients. 
ii)  The  two-stage  exchange  includes  removal  of  the  prosthesis  with  
implantation  of  a  new  prosthesis  during  a  later  surgical  procedure.  The  
two-stage  procedure  has  the  highest  success  rate  usually  exceeding  90% 
iii).Permanent  removal  of  the  device  is  usually  reserved  for  patients  with  
a  high  risk  of  reinfection(eg.  Severe  immunosupression,  IV  drug  users  
etc)  or  when  no  functional  improvement  after  surgery  is  expected. 
In  addition,  for  all  cases  of  ODRI,  a  long  term  suppressive  oral  
antimicrobial  therapy  is  the  main  stay  of  treatment,  Initially  I.V  antibiotics  
for  2-6  weeks  followed  by  oral  therapy  for  3  months  in  case  of  internal  
fixation  and  hip  prosthesis,  6  months  for  knee  prosthesis.                         
Most  of  the  studies(15)  have  shown  that  early  post  operative  
infections  are  associated  with  more  virulent  isolates  like  Staphylococcus  
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aureus,  Klebsiella  species  and  Pseudomonas  aeuroginosa,  whereas  delayed  
and  late  post  operative  infections  are  associated  with  low  virulent  isolates  
like  CONS.   
Antibiotic  treatment  options: 
Many  a  time,  prolonged  administration  of  systemic  antibiotics  may  
not  be  effective,  hence  the  concept  of  local  antibiotic  delivery  system  has  
come  up.  The  advantage  is  extremely  high  level  of  local  antibiotic  
concentration.  This  facilitates  the  delivery  of  antibiotics  by  diffusion  to  
avascular  areas  of  wound.  The  resistant  organisms  start  responding  to  this  
high  concentration.  The  local  antibiotics  can  be  delivered  through  Non-
degradable  beads-PMMA(poly  methyl  metha  acrylate)  beads/Spacers  or  
Bio-degradable  beads  like  bone  graft,  bone  graft  substitutes,  natural  
polymers,  synthetic  polymers,  composite  biomaterials  etc.[5] 
Treatment  of  Gram  Positive  organisms: 
The  main  drugs  used  in  the  treatment  in  case  of  implant  infections  
by  gram  positive  cocci  such  as  staphylococcus  aureus  are;   
i)beta-lactum  antibiotics(penicillins,  third  generation  cepahalosporins,  
monobactums,  and  carbapenems). 
ii)glycopeptides  antibiotics(vancomycin) 
  iii)ribosomal  inhibitor  like  macrolide  licosamide,  streptogramin  B  
(erythromycin,  clindamycin) 
iv)aminoglcosides(gentamycin,  amikacin) 
v)tetracyclines,doxycycline 
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vi)  DNA  gyrase  blocking  drugs(quinolone)  and 
vii)  antimetabolite(trimethoprim)  ,  sulphonamide(sulfamethoxazole) 
Antimicrobial  Resistance  exhibited  by  Staphylococcus  aureus: 
  A)  Resistance  to  beta-lactum  antibiotics-mecA  gene: 
Beta-lactum  antibiotics  interfere  with  synthesis  of  bacterial  cell  wall  
by  inhibiting  transpeptidases  so  that  cross  linking  in  cell  wall  is  inhibited.  
These  enzymes  and  related  proteins  are  called  as  penicillin  binding  proteins  
(PBPs)  located  in  bacterial  cell  membrane.  Penicillin  was  the  first  
antibiotic  to  be  used  clinically  in  1941  and  it  was  the  drug  of  choice  for  
treatment  of  serious  staphylococcus  aureus  infections.  These  organisms  
acquire  resistance  due  to 
i)Acquisition  of  plasmid  borne  genetic  elements  coding  for  beta-
lactamases(penicillinase)  which  opens  the  beta-lactum  ring  and  inactivates  
penicillin. 
ii)  The  presence  of  an  altered    penicillin  binding  proteins(PBP).   
There  are  about  six  different  types  of  PBPs  which  are  mostly  
transpeptidation  enzymes.  PBP  2A  is  mainly  responsible  for  the  emergence  
of  MRSA  and  it  is  encoded  by  a  gene  called  mecA.  The  mecA  gene  
may  be  expressed  by  some  or  all  the  cells  in  a  given  population.   
Methicillin  resistant  staphylococcus  aureus  gene  contains  a  resistant  
island  called  staphylococcus  chromosomal  cassette(SCC)mec.  Here  mec  is  
the  genetic  element  that  confers  resistance  to  methicillin.  Some  
staphylococcus  aureus  lack  mecA  gene  but  exhibit  resistance  to  
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penicillinase  resistant  penicillins.  This  type  of  resistance  is  due  to  
hyperproduction  of  betalactamase  enzyme  which  results  in  slow  hydrolysis  
of  semisynthetic  penicillin.  The  gold  standard  method  of  detection  of  
mecA  gene  in  MRSA  is  PCR(polymerised  chain  reaction). 
There  are  six  types(l  to  Vl)  of  SCCmec  according  to  structure  of  
their  ccrA-ccrB  and  mecA  complexes.  After  emergence  of  MRSA  strains,  
glycopeptides  antibiotics  became  the  drug  of  choice  in  treating  these  
severe  infections.  But  by  May  1996,  Vancomycin  intermediate  
staphylococcus  aureus  (VISA)  was  reported  in  Japan.                           
Vancomycin  acts  by  inhibiting  cell  wall  synthesis  by  binding  to  D-
ala-D-ala  terminal  and  block  both  transpeptidation  and  transglycosylation.  
The  VISA  strains  arises  fron  chromosomal  mutations  that  affect  the  
structure  of  the  cell  wall  peptidoglycan.  VISA  strains  have  thick  cell  wall  
that  contains  increased  number  of  free  uncrosslinked  D-ala-D-ala  terminals  
and  these  act  as  traps  before  glycopeptide  molecules  reach  their  target.   
The  CLSI(Clinical  laboratories  standards  institute)  defines  
staphylococcus  requiring  Vancomycin  concentration  of  ˂  2µg/ml  for  
growth  inhibition  as  susceptible  those  requiring  4  to  8  µm/ml  as  
intermediet  and  those  requiring  ≥16µm/ml  as  resistant 
B)  Resistance  to  Macrolide-Lincosamide-Streptogramins-B(MLS)  group  of  
drugs-erm  Gene:  (16) 
Many  staphylococcus  aureus  strains  have  developed  resistance  to  
macrolide-lincosamide-  streptogramins(MLSb)  which  are  due  to:   
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 Modification  of  target  site 
 Active  efflux  of  the  drug 
 Inactivation  of  the  drug 
The  organism  which  are  resistant  to  Erythromicin  are  almost  resistant  
to  other  MLS  group  of  drugs.These  antibiotic  molecules  bind  to  bacterial  
ribosomes  and  block  protein  synthesis.  Ribosome  modification  is  mediated  
by  erm  gene  which  codes  for  erythromycin  methylase  that  decreases  the  
affinity  of  the  drug  to  its  target.  These  erm  determinants  are  located  in  
mobile  genetic  elements  such  as  transposons  or  plasmids. 
Resistant  Staphylococcus  aureus  to  MLS  group  of  drugs  could  be  
due  to  the  expression  of  erm  gene  and  these  strains  could  be, 
i)constitutively  resistant  strains  that  can  grow  in  the  presence  
of  a  high  concentration  (more  than  100  μg/ml)  of  MLS  
antibiotics  without  prior  induction  and 
ii)  inducibly  resistant  strains  whose  high-level  resistance  to  MLS  
antibiotics  can  be  induced  by  subinhibitory  concentrations  (0.01  
to  0.1  μg/ml)  of  Erythromicin. 
Among  MLSb  drugs  ,  macrolides  are  good  erm  inducers.  Once  
if  they  are  induced  the  gene  product  confers  cross  resistance  to  
other  members  of  MLSb  group  of  drugs,  this  type  is  called  
inducible  resistance(i.e.,diffusion  of  erythromycin  towards  
clindamycin  disk  induces  clindamycin  resistance  as  a  result  the  
zone  of  inhibition  around  clindamycin  takes  D-shape).But  in  
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some  strains  the  erm  gene  undergoes  mutation  and  results  in  
constitutive  resistance  expression(i.e.,inhibition  zone  around  
clindamycin). 
Treatment  of  Gram  Negative  organisms: 
i)Aminoglycosides  like  Amikacin,Gentamicin 
ii)DNA  gyrase  inhibitors  like  Ciprofloxacin,  Ofloxacin. 
iii)  3rd  and  4th  generation  Cephalosporins  like  Cefotaxime,  Ceftrioxazone,  
Ceftazidime 
iv)Anti  pseudomonal  penicillins  like  Piparacillin 
v)beta-lactamase  inhibitor  like  Tazobactum 
Antibiotic  resistance  by  Gram  negative  organisms:   
ESBL(extended  specrum  beta  lactamases)  :  Increased  use  of  antibiotics,  
particularly  third  generation  of  cephalosporins,  has  been  associated  with  
the  emergence  of  β-lactamases  mediated  bacterial  resistance,  which  
subsequently  lead  to  the  development  of  ESBL  producing  bacteria.  ESBL  
are  the  enzymes  that  mediate  resistance  to  extended  spectrum  e.g.,  third  
generation  cephalosporins  as  well  as  monobactams  such  as  
Aztreonam(CLSI,2010).  These  enzymes  catalyze  the  hydrolysis  of  the  β-
lactam  ring  of  antibiotic,  thereby  destroying  the  antimicrobial  activity.  
ESBL  have  been  reported  worldwide  in  many  different  genera  of  
enterobactericeae  and  pseudomonas  aeroginosa.  However  these  are  the  
most  common  in  Klebsiella  pneumoniae  &  E  Coli.  Few  unique  
characteristics  of  ESBL  are  as  follows: 
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a) Mostly  class  A  cephalosporinases  and  are  plasmid  mediated. 
b) More  common  in  Klebsiella  species  followed  by  E  Coli 
c) All  enzymes  are  active  against  Cephalothin. 
d) Imipenam  and  cefoxitin  are  not  hydrolysed. 
e) Comparative  activity  against  cefotaxime  and  ceftazidime  varies  with  
the  enzyme 
f) Inhibition  activity  by  β  –lactamase  inhibitors  can  be  demonstrated. 
The  predisposing  factors  for  ESBL  production  are  prolonged  stay  
in  intensive  care  units,  long  term  use  of  antibiotics,  very  severe  
illness,  extensive  use  of  third  generation  cephalosporins,  use  of  life  
lines  and  catheters. 
TEM  type  of  ESBLs  are  the  derivatives  of  TEM-l  and  TEM-2.  
TEM-1  was  first  discovered  in  a  patient  called  Temonieria  and  
named  as  TEM.  More  than  100  types  of  TEM  ESBLs  have  been  
described.  TEM-1,  2,  13  are  not  ESBLs. 
SHV  was  named  so  because  they  are  sulfhydryl  variable.  They  are  
the  most  commonly  found  type  of  ESBL  in  the  clinical  isolates.  It  
was  first  isolated  from  Klebsiella  ozaenae  in  1983.  More  than  50  
types  have  been  reported  so  far.   
CTX-M  are  ESBLs  which  have  tendency  to  hydrolyse  Cefotaxime  
more  than  Ceftazidime  and  also  hydrolyse  Cefepime  with  more  
efficiency.  More  than  113  types  have  been  described. 
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OXA-β  lactamases  have  the  ability  to  hydrolyse  Oxacillin  and  
Cloxacillin.  The  other  types  of  ESBL  includes  PER1-2,  VEB1-2,  
GES,  SFO,  IBC  etc. 
Recent  reports  describe  ESBLs  a  global  threat  to  health(Pitout  and  
Laupland,2008)  and  the  Infectious  Disease  Society  of  America  has  listed  
the  ESBL  producing  Enterobacteriaceae  as  one  of  the  six  problematic  
drug-resistant  pathogens  and  reported  the  urgent  need  for  newer  and  more  
effective  therapeutics. 
Prevention  of  ODRI  infection   
1) Preoperative  methods 
 Patient-specific  factor  optimisation 
 MRSA  decolonization   
 Skin  disinfection 
2) Intraoperative  methods 
 Antibiotic  prophylaxis 
 Cutaneous  preparation(hair  removal,  skin  antisepsis,  and  
surgical  draping) 
 Operative  environment(operating  theatre  ventilation,  body  
exhaust  suits,  gloves,  and  intraoperative  lavage) 
 Blood  conservation 
 Prosthesis  selection 
3) Postoperative  methods: 
 Antibiotic  prophylaxis 
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 Evacuation  drains 
Antimicrobial  prophylaxis: 
The  aim  of  antibiotic  prophylaxis  is  to  ensure  effective  serum  and  
tissue  levels  of  drugs  during  surgery.  Certain  guidelines  were  
recommended  to  start  antimicrobial  prophylaxis  before  surgery,  they  are   
 Prophylactic  antibiotics  should  be  initiated  within  1  hour  before  
incision 
 Antibiotics  should  be  administered  in  accordance  with  surgical  
procedure 
 Prophylactic  antibiotic  should  be  discontinued  within  24  hours  of  
surgery  except  cardiothoracic  surgery  (discontinued  within  48  hours) 
A  multicentric  study  conducted  in  united  states  proved  that  of  
antibiotics  administered  within  1  hour  before  surgery  reduce  infection  rate  
and  this  was  reduced  further  if  administered  within  30  minutes  before  
incision.   
Single  infusion  of  antibiotics  given  1  hour  before  incision  gives  
sufficient  protection  and  it  has  to  be  repeated  intraoperatively  for  
procedures  lasting  more  than  24hours  and  when  substantial  blood  loss  
occurs.  Antibiotics  must  be  present  in  the  surgical  site  throughout  the  
surgical  period.  There  is  no  benefit  in  continuing  antibiotic  prophylaxis  
after  24  hours  of  surgery  except  cardiac  surgery. 
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Treatment  of  orthopaedic  device  related  infections  is  a  scenario  
where  many  variables  play  a  role  in  deciding  the  treatment.  Therefore,  
the  best  treatment  strategy  is  prevention  of  infection.  Antimicrobial  
prophylaxis  remains  the  most  effect  method  of  reducing  the  prevalence  
of  infection  in  fracture  fixation  surgeries.   
In  orthopaedic  surgery,  a  first-generation  or  second  generation  
cephalosporin  ,  such  as  cefazoline  or  cefuroxime,  is  a  rational  choice.  If  
the  patient  is  allergic  to  cephalosporins  or  in  settings  with  high  prevalence  
of  methicillin  resistant  S.  aureus(MRSA),  vancomycin  or  teicoplanin  are  
alternative  options.   
For  optimal  efficacy  of  the  prophylactic  agent  ,  antimicrobial  
inhibitory  concentrations  must  be  achieved  in  tissues  at  the  time  of  
incision  and  last  during  the  entire  procedure.  When  a  tourniquet  is  used,  
tissue  concentrations  of  the  antibiotic  are  usually  insufficient  for  prevention  
of  implant  infection  when  administer  5  min  before  inflation  or  later.   
For  internal  fixation  devices  of  closed  fractures  in  centres  with  
infection  rates  of  less  than  5%,  a  single  dose  of  intravenous  cefuroxime  
is  a  reasonable  option.  In  centers  within  known  or  high  infection  rates(>  
5%)  and  in  open  fractures  grade  l  and  grade  ll  ,  a  1-  day  prophylaxis  is  
preferred  :  intravenous  cefuroxime  and  /or  tazobactum-pipracillin  may  be  
used.  In  patients  with  internal  fixation  of  grade  lll  open  fractures,  
preventive  therapy  with  an  anti  staphylococcal  drug  such  as  intravenous  
amoxicillin/clavulanic  acid  or  cefuroxime  for  5-7days  is  reasonable.   
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Haematogenous  seeding  of  implants  may  occur  during  the  whole  
life,  although  the  risk  of  infection  is  highest  in  the  first  year  after  
implantation.  The  most  frequent  sources  of  haematogenous  infection  are  
infections  of  skin  and  soft  tissues,  oral  cavity,  urinary  and  respiratory  
tract.  They  must  be  tackled  accordingly.     
         
  
  
 
 
 
 
 
 
 
 
 
 
 
MATERIALS & METHODS 
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MATERIALS AND METHODS 
Place of Study 
            This study on “Isolation and characterisation of bacterial pathogens in 
orthopaedic implant associated infections” was conducted  in the Department 
of Microbiology, Coimbatore Medical College Hospital, Coimbatore. 
Study design 
           A hospital based Prospective Study 
Duration of study 
            The study was conducted for a period of one year from July2016 to 
June2017 
Approval 
            Ethical clearance was obtained from Institutional Ethics Committee 
prior to the conduct of the study and informed consent was obtained from all 
patients included in the study. 
Sample size 
           This study was carried out in 136 cases with implant infections from 
patients admitted  in orthopaedic and plastic surgery wards. 
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Data Analysis 
          Data entry was made in the Excel Software and Analysis was done with 
SPSS-24 computer package. The categorical variable is expressed in frequency 
and percentage. The continuous variable is expressed in terms of mean and 
standard deviation. The associations between variables was found by chi-square 
test and independent sample t-test P value <0.05 was considered  statistically 
significant. 
Inclusion criteria 
1) Patients with implant infections in orthopaedic and plastic surgery wards 
2) Patients of all age groups and both sexes with implant infections. 
3) Patients with open/closed fracture. 
4) Surgeries including emergency and elective procedures. 
Exclusion criteria 
1) Implantation done through already infected wound. 
2) Patients on long term steroids and immunosuppressive therapy. 
3) Patients with chronic illness like Tuberculosis, Malignancy. 
4) Patient with concurrent urinary tract infection. 
Evaluation 
          Data collection include name, age, address, date of admission, diagnosis 
at admission, physical examination finding, duration  of  hospital stay, 
nutritional  status, type of implant, duration of procedure, any underlying 
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illness(urinary tract infection, respiratory tract infection),co morbid 
conditions(diabetes mellitus, tuberculosis, malignancy),drug history(steroids, 
immunosuppressivedrugs),smoking and alcoholism were also recorded. 
Sample collection and transportation 
  The pus samples were collected aseptically from patients presented with 
clinical evidence of infection (purulent discharge from incision site or drain or  
implant ) using  sterile cotton swabs from surgical site after cleaning  the 
surrounding area with sterile normal saline without touching the wound to 
prevent contamination by skin commensals. In patients with deep seated 
abscesses, using sterile syringe under aseptic precaution pus was aspirated and 
transported to the laboratory immediately for further processing. 
               Anaerobic cultures were done in cases of suspected anaerobic 
infections. Specimens of infected tissue bits and periprosthetic  membrane  were 
collected during wound debridement  in a sterile container containing  
thioglycollate broth. Gaspak method was used to maintain oxygen free 
environment during processing of specimen.  
Processing of specimens 
              After proper sample collection under aseptic precaution the same were 
processed as follows, 
 Direct microscopic examination of Gram stained smear 
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 Inoculation of samples into Nutrient agar, Blood agar, MacConkey agar, 
and selective media such as Mannitol salt agar 
 Thioglycollate  broth was inoculated for the isolation of anaerobic 
organisms 
 Preliminary identification of growth by colony morphology 
 Biochemical tests for characterisation of species 
 Antibiotic sensitivity test 
Direct Gram’s Stain 
               For microscopic examination of pus cells and  bacteria, the smear was 
prepared by rolling the pus culture swab on to the surface of a clean, dry sterile 
glass slide. The smear was allowed to air dry and then gently heat fixed. 
              Smear was stained by Gram staining method. Once stained the smear 
was examined under low power microscope for the presence of pus cell, debris, 
and fungi. Next the smear was evaluated under oil immersion method in 100x 
objective  for the presence of  bacteria as well their Gram reaction, morphology 
and arrangements of  the  cells.  
Culture for Aerobic organisms: 
                 The pus culture  swab was inoculated on to Nutrient agar plate, 5% 
sheep blood agar, MacConkey agar plate and by using sterile bacteriological 
loop  streak culture done and plates were  incubated at 37ºC for 24-48 hours. 
The blood agar plate was incubated at 5-10% CO2 
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Culture for Anaerobic organisms: 
                      Specimen(aspirated pus or infected tissue bits or periprosthetic 
membrane)from thioglycollate broth was plated on anaerobic blood agar plates 
by streak culture method. The plates were placed   in the anaerobic gaspak 
system with a chemical and a biological indicator(pseudomonas aeruginosa)  
and  incubated  at 37ºC for 24 hours. 
             After overnight incubation, culture plates were observed for growth. If 
there was no growth, plates were further incubated for 48 hours and reported as 
no growth. The plates which were kept in the anaerobic gaspak system, were 
observed daily for any  growth for minimum of  seven days before reported as 
no growth. If growth was present identification of organisms were done by 
observing  their colony  morphology, culture characteristics, Gram staining  and 
biochemical reactions. 
   Biochemical tests: 
 Catalase 
 Modified oxidase  
 Mannitol salt agar test 
 Urease test 
 Slide and Tube coagulase test 
 Bile esculin test 
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In case of Gram negative isolates, hanging drop for motility, Catalase, Oxidase, 
Triple sugar iron(TSI), Nitrate reduction test, 
Lysine,Arginine,Ornithine(LAO)test, Oxidation and fermentation test(Hugh & 
Leifson) were also done. 
Catalase test 
             This test demonstrates that presence of enzyme catalase which is 
present  in most of the cytochrome containing aerobic and facultative anaerobic 
bacteria. Catalase is capable of converting hydrogen peroxide(one of the 
oxidative end product of aerobic carbohydrate metabolism) to water and oxygen 
as accumulation of this is lethal to the bacteria. 
              Using a sterile glass rod, a small amount of colony is transferred to 
glass tube containing 3% hydrogen peroxide. The rapid and sustained 
appearance of effervescence indicates positive test 
Oxidase test 
                This test is done to determine the presence of bacterial cytochrome 
oxidase. Oxidation of the substrate tetramethyl –p-phenylene diamine 
dihydrochloride to indophenols which is  a dark purple colored end product, 
indicates a positive test.  
          A small amount of colony was streaked on to the moistened filter paper 
disks, impregnated with freshly prepared 1% tetramethyl paraphenylene 
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diamine dihydro chloride. An intense deep blue colour appearing within 5-10 
seconds was taken as positive reaction. 
Mannitol fermentation test 
                  Colonies of Staphylococcus aureus was streaked on to mannitol salt 
agar (1% mannitol, 7.5% sodium chloride, phenol red and peptones) and 
incubated for 24-48 hours at 37ºC. High salt concentration of medium allows 
the growth of  Staphylococci and inhibit the growth of other organisms(except 
enterococci) 
Interpretation: 
Yellow zone around colonies indicating acid production from mannitol 
Urease test  
             This test is used to determine the ability of the organism to produce the 
enzyme urease which hydrolyzes the urea to ammonia which results in alkaline 
pH & change of colour.  
              The surface of the agar is streaked with the test organism and incubated 
at 35ºC for 18 to 24 hours. The appearance  of pink colour indicates the 
production of enzyme urease. 
Coagulase test 
              This test is done to differentiate Staphylococcus aureus  from 
coagulase negative staphylococci. It can be done by slide and tube method. 
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Slide coagulase test 
                       This test detects bound coagulase. A colony suspected to be 
Staphylococcus species was emulsified with sterile saline on a clean glass slide 
to form a milky suspension. A drop of citrated human plasma was added to the 
suspension. A similar suspension was made with known staphylococcus strains 
to test the proper reactivity of plasma. Presence of coarse clumping of cocci 
within 10 seconds indicates that organism was slide coagulase positive. It was 
confirmed by tube coagulase test. 
Tube coagulase test 
              This test detects free coagulase. Few colonies from blood agar plates 
were mixed with 0.5ml of diluted plasma in the test tube. Positive control, 
Negative control, and a tube of undiluted plasma were also kept ready. Tubes 
were incubated at 35ºC for 24 hours. They were examined at 1, 2, and 4 hours 
for clot formation. The plasma was converted into a stiff gel that remained in 
place when the tube was tilted. If no clot was seen, the tube was re-incubated  
at room temperature and it was read again after 18 hours. Clot formation 
confirmed the slide test and the organism was identified as Staphylococcus 
aureus. 
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Detection of Enterococci: 
Bile esculin test  
              Few colonies from 18-24 hours pure culture was inoculated on to the 
surface of bile esculin agar slant. Ferric ammonium citrate was used as an 
indicator and incubated for 24-48 hours at 35ºC 
Interpretation: 
Positive: Diffuse blackening of more than half of agar slant.  
Negative: No blackening of medium was seen. 
PYR test(L-pyrro glutamyl aminopeptidase test) 
             Streptococcus pyogenes and Enterococci isolates were subjected to 
PYR test. The bacterial  colony inoculated into  L-pyrrolidonyl-β- 
Napthylamide agar and incubated at 35-37ºC for 18-24 hours. Presence of the 
enzyme L-pyrrolidonyl arylamidase in Streptococcus pyogenus or  
Enterococcus fecalis hydrolyses the substrate and forms β-Napthylamine.  
             The colonies are picked up with a sterile cotton swab and a drop of  
PYR reagent (N-N-dimethl cinnamaldehyde) was added to the swab. 
Developement  of red  colour(positive reaction) within 5-10 minutes was 
observed. 
Sugar fermentation test 
              This test is to determine the ability of organism to ferment 
carbohydrates. A single colony or a drop of liquid culture was inoculated into 
5ml of peptone water in a test tube containing 1% sugars(glucose, lactose, 
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sucrose, maltose, mannitol etc) with a Durham’s tube in it and Bromothymol 
blue  as indicator and incubated at 35ºC for 24-48 hours.  
Interpretation: 
Acid production: Blue coloured medium turns yellow due to acid production 
Gas production: Presence of gas bubbles in Durham’s tube.  
Citrate utilization test: 
               A well isolated colony was picked up from the he slant surface of 
MacConkey agar plate and inoculated on to the slant surface of  Simmon’s 
citrate agar medium and incubated at 35ºC for 24 to 48 hours. Colour change of 
medium from green to deep blue with visible colony growth along the streak 
line was interpreted as positive 
Triple sugar iron agar test(TSI) 
            TSI is used to determine whether Gram negative bacilli ferments 
glucose, lactose or sucrose and forms hydrogen sulphide(H2S). 
             Touch the top of a well isolated colony with the help of straight 
inoculation needle and inoculate into TSI media by first stabbing through the 
centre of the medium up to half of the butt  and then streaking  the slant surface. 
Incubate the tube at 35ºC in ambient air for 18 to 24 hours. The change in colour 
of the slant/butt with or without gas and black precipitate is noted. 
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Nitrate reduction test 
              This is done to determine the ability of the organism to reduce nitrate 
to nitrite or free nitrogen gas. Test organism was inoculated onto the nitrate 
reduction broth which contains large amount of nitrate (KNO3). After 
incubation at 35ºC for 48 hours, alpha napthylamine and sulfanilic acid are 
added. If  nitrate reducing bacteria is present, it will reduce nitrate to nitrite  
which turns the broth into red colour on adding these two compounds. 
Decorboxylase test(Lysine, arginine, ornithine)Moeller’s method 
              This test is used to differentiate decorboxylase producing 
Enterobactericeae from other Gram negative bacilli. This test is done to 
determine the ability of an organism to decorboxylate an amino acid to form an 
amine with resulting alkalinity. 
              Test organism is inoculated into one tube containing base(Moeller 
decorboxylase medium) with amino acid to be tested and other tube containing 
only the base which act as a control tube. Overlay both the tubes with sterile 
mineral oil for about 1cm of the surface and incubate at 35ºC for 18-24 hours. 
                The appearance of yellow colour in the control tube indicates that the 
organism is viable and pH of the medium is sufficiently lowered to activate the 
decorboxylase enzymes. Reversion of the tubes containing amino acid to a blue 
purple colour indicates a positive test. 
Oxidation fermentation test(Hugh & Leifson) 
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             Principle: To determine the oxidative or fermentative metabolism of a 
carbohydrate  
              Fermentation is an anaerobic process and bacterial fermenters of 
carbohydrates are usually facultative anaerobes. Oxidation is an aerobic process 
and bacterial oxidizers are usually strict aerobes. 
               It employs a semi-solid medium in tubes containing the carbohydrate 
under test and a pH  indicator. Two tubes are inoculated and one is immediately  
overlayed with sterile paraffin oil and sealed to produce anaerobic conditions. 
Oxidizing organisms produce an acid reaction in the open tube only. Fermenting 
organisms produce an acid reaction throughout the medium in both tubes. 
Organisms that cannot breakdown the carbohydrate aerobically or 
anaerobically  produce an alkaline reaction in the open tube and no change in 
the covered tube.  
Antimicrobial susceptibility test 
             Antimicrobial sensitivity test for all isolates were performed by Kirby-
Bauer disc diffusion method on Mueller Hinton agar plate as per CLSI 
guidelines. Antibiotic discs were procured from Himedia Labs Mumbai. 
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Inoculum  preparation 
            Using sterile wire loop, 3-4 well isolated colonies of the organism was 
taken and inoculated into 2-3 ml of peptone broth. Incubate at 37ºC for 2-6 
hours to attain a turbidity which corresponds to 0.5 McFarland standard. 
Preparation of 0.5 McFarland standard 
           It is prepared by mixing 1% sulphuric acid and 1.175% barium chloride 
to obtain a solution with a specific optical density which is comparable to the 
density of bacterial suspension of  1.5x10 CFU/ml. 
Inoculation of test plates 
                 After adjusting the turbidity of  suspension, a sterile cotton swab was 
dipped into the adjusted suspension. The excess inoculums was removed by 
pressing the swab firmly on the inside wall of the tube above the fluid level.  
                 To the dried surface of Mueller-Hinton agar, the swab was streaked 
on the entire surface of the agar plate. The plates were dried for few minutes 
with lid closed. Commercially available antibiotic disks obtained from Hi-
Media laboratories Limited were used. Using a sterile forceps the antibiotic 
disks were placed (6 disks for one 90mm plate) on the inoculated plates and 
gently pressed to ensure even contact and incubated at 37ºC.  
               After 16-18 hours of incubation the diameter of each zone size 
measured using Antibiotic Zonescale and recorded in mm. Once zone size have 
been measured interpretive criteria are assigned based on CLSI-M2 series“ 
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Performance Standards for Antimicrobial Disk Susceptibility Tests”(M100-
S24Suppliments) 
                     Antibiotic discs used for Gram positive isolates were 
Cotrimoxazole 
(25µg),Penicillin10units,Gentamicin(15µg),Amoxicillin(30µg),Erythromycin(
15µg), Azithromycin(15µg), Clindamycin(2µg), Cephalexin(30µg), 
Cefoxitin(30µg), Doxycycline(30µg), Ciprofloxacin(5µg)  Linezolid(15µg),  
and Vancomycin. 
                     Antibiotic discs used for Gram negative isolates were 
Gentamycin(30µg),Amikacin(30µg),Ciprofloxacin(5µg),Cefazoline(30µm),C
eftrioxone(30µg),Ceftazidime(30µg),Cefotaxime(30µg),Cefipime(30µg),Amp
icillin-Sulbactum(10µg),Meropenem(10µg), and Pipracillin-Tazobactum 
(100µg) were used. 
  Phenotypic screening test for Staphylococcus aureus 
             The Staphylococcus aureus isolate was inoculated in nutrient broth and 
incubated till the inoculum reaches 0.5 McFarland turbidity, and following 
phenotypic screening tests were performed. 
Screening test for mec-A mediated Oxacillin resistance 
                A lawn  culture was done in MHA plate as for standard disc diffusion 
by Kirby-Bauer method. Cefoxitin 30µg  disc was placed and incubated at 35ºC 
in ambient air for 24 hours. The AST plate was examined in reflected light, a 
61 
 
zone of inhibition below 21mm is taken  as mec-A positive(MRSA) and zone 
diameter more than 22mm is taken as mec-A negative (MSSA) strain. 
                Methicillin resistance is mediated by acquired penicillin binding 
protein 2A (PBP2A), encoded by chromosomal gene called mec-A.PBP2A has 
special requirement for peculiar cell wall precursors. The strains positive by this 
test were labelled as Methicillin Resistant Staphylococcus aureus (MRSA). 
Cefoxitin is used as a surrogate marker for MRSA. 
Inducible Clindamycin resistance D-test  
            A lawn culture of Staphylococcus aureus isolate was done in MHA 
plate. Macrolide antibiotic Erythromycin 15µm disc was placed and 
Lincosamide antibiotic Clindamycin 2µm disc placed 15-25 mm apart. The 
plate was incubated in 35-37ºC in ambient air for 16-18 hours. 
              Flattening of zone of inhibition around clindamycin adjacent to the 
erythromycin disc resulting in D-shape was considered positive. The inducible 
resistance is due to erm B gene of Staphylococcus aureus and macrolides are 
potent erm B inducers. If there is no zone of  inhibition around clindamycin it 
is taken as constitutive resistance. 
  
62 
 
Screening of  Vancomycin Minimal Inhibitory Concentration (MIC) by E 
test 
             Vancomycin disc diffusion does not differentiate between Vancomycin 
susceptible isolates from Vancomycin  intermediate isolates. The high 
molecular weight antibiotics like Vancomycin do not diffuses according to 
concentration gradient, while diffusing through the MHA medium. 
             MIC is the lowest concentration of antimicrobial agent that inhibits 
visible growth. Commercial method of MIC  determination is done by E test 
(Himedia Ezy MIC strip Van 0.16-256 mcg/ml). 
             A lawn culture of the inoculum was made in MHA plate and E strip 
was brought to room temperature. By using the adhesive applicator stick the E 
strip placed in the centre of the plate and the applicator stick removed gently. E 
strip will be adsorbed and will firmly adhere to the agar surface immediately. 
The MHA plate was then incubated at 35ºC for 24 hours. MIC is determined by 
examining the point of intersection of bacterial growth with graded 
concentration of Vancomycin in the E strip which has MICs in the range of 
0.016 mcg/ml to 256 mcg/ml.  
            The interpretive criteria for identifying Vancomycin sensitive, 
intermediate, and resistant Staphylococcus aureus by E test method are as 
follows: 
 Sensitive if MIC less than 2 mcg/ml. 
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 MIC in between 4-8 mcg/ml is considered as intermediate resistant 
(VISA). 
 MIC above 16mcg/ml by E test is considered as Vancomycin resistant 
Staphylococcus aureus (VRSA) 
 
Laboratory methods for identification of Extended Spectrum Beta 
Lactamases(ESBL) 
          Gram negative bacteria which are resistant to third generation 
cephalosporins (Cefotaxime, Ceftriaxone, Ceftazidime, Cefpodoxime) are 
screened for ESBL production.  
ESBL Screening test 
           The current Clinical laboratory standard Institute(CLSI) guidelines for 
detection of ESBL includes initial screening test with any four  of the following 
betalactum antibiotics: Cefpodoxime, Cefotaxime, Ceftriaxone, Ceftazidime, 
Aztreonam. The use of more than one antimicrobial agent for screening 
improves the sensitivity of detection. Cefpodoxime and Ceftazidime shows the 
highest sensitivity for ESBL detection. In the present study screening was done 
by using Cefpodoxime, Cefotaxime,Ceftriaxone, and Ceftazidime. 
             A  lawn culture of the test inoculums was made in Mueller-Hinton agar 
plate and antimicrobial discs (Cefpodoxime10µg, Cefotaxime 30µg, 
Ceftriaxone 30µg, Ceftazidime 30µg) were placed and incubated at 35-37ºC for 
16-18 hours. After  incubation the AST plate was examined and zone size 
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measured. Zone size of (Cefpodoxime ≤ 17, Cefotaxime ≤ 27, Ceftazidime ≤ 
22, Ceftriaxone ≤ 25) indicates ESBL production. 
ESBL confirmatory tests 
              Phenotypic confirmatory testing depends on demonstrating a synergy 
between Clavulanic acid and an indicator Cephalosporin. Many variations of 
confirmatory testing have been described but few are convenient for routine 
use: combined disc method, double disc(DD)approximation test, minimum 
inhibitory concentration (MIC) methods, and E –test ESBL strips. The CLSI 
recommends the combined disc method, and the MIC method for ESBL 
confirmation. In the present study combined disk test was used for phenotypic 
confirmation. 
Combined disk test 
               It  depends  on  comparing the inhibition zones around disks 
containing an indicator Cephalosporin with and without Clavulanic acid. As per 
CLSI guidelines, 10µg of Clavulanic acid is added to each of a Cefotaxime 
(30µg) and a Ceftazidime (30µg) disk. If ESBL is produced,  the zone diameters 
given by the disks  with Clavulanic acid are > 5mm larger than those without 
the inhibitor. ESBL production is inferred if the zones given by the disks with 
clavulanate > 5mm larger than those without the inhibitor. 
 
Molecular Identification of Antimicrobial Resistance Gene: 
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Materials & Methods: 
                    Purefast Bacterial DNA minispin purification kit [Kit contains 
Lysozyme, Lysozyme digestion buffer, Proteinase-K, Binding buffer, Wash 
buffer-1, Wash buffer-2, Spin columns with collection tube and Elution buffer]. 
HELINI 2X RedDye PCR Master mix, Agarose gel electrophoresis 
consumables and MecA Primers are from HELINI Biomolecules, Chennai, 
India. 
2X Master Mix: 
                   It contains 2U of Taq DNA Polymerase, 10X Taq reaction buffer, 
2mM MgCL2, 1µl of 10mM dNTPs mix and RedDye PCR additives. 
Agarose gel electrophoresis:  
                    Agarose, 50X TAE buffer, 6X gel loading buffer and Ethidium 
bromide are from HELINI Biomolecules, Chennai. 
PCR: 
HELINI Ready to use MecA gene Primer mix-5µl/reaction 
PCR Product size: 200bp 
Bacterial DNA Purification done as per the Purefast Bacterial DNA minispin 
purification kit protocol. 
 
PCR Procedure: 
1. Reactions set up as follows; 
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HELINI RedDye PCR Master mix- 10µl 
HELINI Ready to use gene primer mix- 5µl 
Purified Bacterial DNA- 5µl 
Total volume- 20µl 
2. Mixed gently and spin down briefly 
3. Place into PCR machine and programmed it as follows 
Initial Denaturation: 94°C for 5min 
Denaturation: 94°C for 30 sec   }                                                                                                                          
Annealing: 58°C for 30 sec        }   35 cycles 
Extension: 72°C for 30 sec        } 
Final Extension: 72°C for 5min 
Loading: 
1. Prepared  2% Agarose gel.(2gm of agarose in 100 ml of 1X TAE buffer) 
2. Run electrophoresis at 50 V till the dye reaches three fourth distances and 
observe the bands in UV transilluminator. 
Agarose gel electrophoresis: 
                The PCR Products were analysed by Gel electrophoresis with 2% 
agarose in 1X TAE buffer with Ethidium bromide (5µl/ml) and visualised by 
UV- transillumination. A 100 base pair (bp) DNA ladder (HELINI, Chennai) 
was used as a marker. Duplex- PCR yielded products with size of 200 bp which 
corresponds to MecA gene. 
  
  
Figure 1: Gram  Stain  -  Gram positive  cocci  in  clusters  of  
Staphylococcus  aureus. 
Figure 2:  Nutrient Agar – Golden yellow colonies of  
Staphylococcus  aureus. 
  
Figure 3:  Beta  hemolytic  colonies  of  Staphylococcus  aureus 
in  5%  sheep  blood  agar. 
Figure 4a: Tube coagulase test 
Plasma control 
Tube coagulase positive 
Figure 4b:  Mannitol  Salt  Agar– Yellow 
colonies of  Staphylococcus  aureus. 
  
Figure 5b: Gram stain showing Gram 
negative bacilli 
Figure 5a: Direct Gram stain showing 
pus cells and Gram negative bacilli 
Figure 6:  MacConkey Agar: 
Mucoid Lactose Fermenting Colonies 
of Klebsiella 
Figure 7: MacConkey Agar – Flat  lactose  
fermenting  colonies  of  E.coli 
  
Figure 8: Nutrient agar –Pigmentation of 
Pseudomonas aeruginosa  
Figure 9: Blood Agar Plate  -  
Swarming growth of Proteus 
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Figure  10: Biochemical reactions of Pseudomonas aeruginosa 
   
Figure 11:  Antibiotic  Sensitivity of Staphylococcus  aureus  by 
disc  diffusion  method 
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Figure 12:  E  Strip  showing  Vancomycin  sensitivity  of  less 
than  2µg/ml  for  Staphylococcus  aureus 
  
Figure 14:  Inducible  Clindamycin  resistance   D-Test 
Figure 13:  Antibiotic susceptibility of S.aureus 
 resistant to Cefoxitin (MRSA) 
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Product (mec A gene) 
NTC – Negative Template Control 
Lane M shows DNA ladder molecular marker 100bp 
Lane 1 – 11 shows MRSA strains and a positive control 
Test sample showing 200bp gene products for mec A gene 
Sample 2 – Negative for mec A gene 
 
  
Figure 15:  Agarose gel electrophoresis of PCR 
Lane M 
Lane 1-11 
  
Figure 17:  Phenotypic confirmation  of ESBL by combined disc method 
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Figure 16:  Phenotypic  screening  of ESBL by using 4 drugs 
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Figure 18:  Fracture Tibia with Open Wound 
External Fixator in Situ 
 
Figure 19:  Implant – External Fixator Figure 19:  Implant – Dynamic Hip Screw 
  
 
 
 
 
 
 
 
 
 
 
 
 
RESULTS 
67 
 
RESULTS AND ANALYSIS 
                       A   total  of  137  orthopaedic  device   related   infection ( ODRI) 
cases   were  subjected  for  culture  and  sensitivity  and  their  antibiotic 
resistance  pattern  were  analysed  in  this  study .  
                    In a  study  period  of  one year (from july16 to june17), 1987 
patients had  undergone  implant  surgeries.  Out  of  which  137   were  clinically 
diagnosed as  ODRI ‘ s  and  subjected  for culture and sensitivity.  Out  of these 
,  n = 116  ( 85% )  were  culture  positive  and  n= 21  ( 15%)   were  culture  
negative .  (  Refer  table  no: 1) .  
                Among  116   culture  positive   cases  ,  the  nature  of injury  
commonly  observed  was  Road  traffic  accident   n=84 ( 72% ). The  other 
causes of injury associated with  ODRI ‘ s  were   self  fall   n= 24 ( 21%) , work 
spot injury n= 4 (4%),  others  (  animal  attack  )  n= 3 ( 2 %) and  assault  n=1 
( 0.8%) .  Refer  table no :2 . 
                    Distribution  of  onset of infections  was  common  in  early/ acute   
infection n= 91( 79 % ) . Delayed  infection was  observed  in n=  16 (13%)  and  
chronic  infection  shows  culture  positive  in  n= 9 (8%) .(  Refer  table  no: 3) 
                      The  percentage  of   culture  positive  in  ODRI ‘s  was  observed  
more commonly  in  open  fractures  n= 82 (  71%), and less commonly  n= 34 
(29%) in closed type of fractures. (Refer table no : 4). 
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                      In  emergency  surgery , the  percentage  of  implant  infection  
was observed  in  n= 74 ( 64%),  and  n= 42  ( 36%), in elective surgery cases.   
Refer  table  no: 5 
                     The most common  risk  factor  associated  with  implant  infection  
was  Diabetes  mellitus  n= 42 (36%) .Smokers and alcoholics  developed  
implant infection in n= 26 ( 23%)  and  n= 25 (21%)  respectively.  Patients  
with anaemia  developed  infection in  n= 9( 8%)  and  those  with  chronic  liver 
disease,  chronic kidney  diseases, systemic  hypertension showed  infection  in  
n=8 (7%), and    patients  n= 6 (5%)developed  implant  infection  even without  
any  risk  factor.  (Refer  table   no: 6) 
                    Out  of  116  culture  positives ,  implant  infections  were observed  
commonly  in  age  group  of  36-45  yrs , n= 35 (  31%) . The  next  common  
age  group  involved  in  implant  infections were 46-55 yrs ,n=23 (20%) and 
26- 35 yrs , n=21(18%). Implant infections were low in 5-15 yrs n=5 (4%) .( 
Refer  table no:7 ) 
                  Implant  infections  were  more common  among  males n=87 (75%)   
than  females  n=29 (25%) . Refer  table no: 8 . 
                   Out  of  116 culture  positive  cases,  Staphylococcus aureus was 
the most  common  pathogen 34(29%),  followed  by  Klebsiella spp 21(18%),  
Pseudomonas aeruginosa 15(13%),  Proteus spp 14(12%),  CoNS 9(8%), E Coli 
8( 7%), Acinetobacter 3(3 %),  Enterococcus fecalis 1(0.8%), and 
Polymicrobial 11(9%) (refer table: 9 ) 
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         ……..  A  total  of  (n=34), staphylococcus aureus isolates  showed 100% 
sensitivity to Linezolid  and Vancomycin,  76%    sensitivity  to  Cephazolin 
and  59%    sensitivity  to  Amoxycilllin, Gentamicin, and Cephalexin,  56% 
sensitivity to Clindamycin,  50% sensitivity to  Erythromycin and 46% 
sensitivity to Doxycycline. Cefoxitin sensitivity was 32% .Drugs such as 
Cotrimoxazole, Ciprofloxacin showed 15% sensitivity    Refer  table  no : 10) 
                            Among   34  Staphylococcus aureus, n=11 ( 32.3% ) of  the   
isolates were  found to be MRSA (Methicillin resistant Staphylococcus aureus) 
and  23 isolates were MSSA(Methicillin sensitive Staphylococcus 
aureus).(Refer table number; 11) 
 All MRSA strains showed  100%  sensitivity   to  Linezolid  and  Vancomycin 
.  (Refer   table  no : 13) 
                       Genotyping of  all MRSA (n=11) strains were done, among the 
11 resistant isolates, 10 (90.9%) resistant isolates showed  mec-A gene positive.  
(Refer  table  no  :  12) 
              Coagulative negative Staphylococcus species (n=9) showed  100 %  
sensitivity  to  Linezolid   and  Vancomycin . Amoxyclave showed sensitivity 
of 89% and  Amoxycillin(77%).  50-60% sensitivity to Cotrimoxazole and  
Gentamicin Clindamycin showed sensitivity of 45%.(Refer table no:10) 
                One isolate of  Enterococcus fecalis in this study showed 100% 
sensitivity to Amoxyclav, Ciprofloxacin, Clindamycin  ,  Linezolid  and 
Vancomycin. ( Refer  table  no :  10 ) 
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            All the gram negative bacilli and Pseudomonas in this study showed 
100% sensitivity to Meropenum.(Refer table;13)     
              Klebsiella spp(n=21) showed 100%  sensitivity   to  Amikacin,  and  
sensitivity of 76% for Ciprofloxacin. Antibacterials such as Gentamicin, 
Cotrimoxazole,   Amoxycillin,  Cefotaxime,  Ceftazidime,  Piperacillin-
Tazobactum,  Cefaperazone-Sulbactum showed relatively less 
sensitivity.(Refer table:13)  
                Among the Psuedomonas aeruginosa(n=15) all the isolates showed 
100% sensitivity to Amikacin, and 73% sensitivity to Ceftazidime. Sensitivity 
to Pipracillin-Tazobactum,  was 67%,. Tobramycin showed sensitivity of 53%  
and  Gentamicin,   Ciprofloxacin  showed  sensitivity  of 40-50%.(Refer table 
no:13) 
                   Among the 14 isolates of  Proteus spp, many  of  the  isolates  
showed 80-90% sensitivity to Amikacin. Drugs such as Piperacillin-
Tazobactum and Ciprofloxacin  showed sensitivity of 64% and 50% 
respectively.  Very low sensitivity to  Cotrimoxazole, Amoxycillin, Gentamicin 
and Cefotaxime..(Refer table:13) 
                 E Coli isolates(n=8) showed sensitivity of 80-90%  to Ciprofloxacin, 
Amikacin. Drugs such as Amoxycillin, Cotrimoxazole, Gentamicin, 
Cephalexin, and Cefotaxime  showed  less sensitivity.(Refer table;13)  
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                    Acinetobacter spp(n=3), showed 100% sensitivity to Pipracillin-
Tazobactum,  and Meropenem. Amino glycosides such as Tobramycin showed 
66% sensitivity and Amikacin 33%  sensitivity(Refer  table  no: 13) 
                    ESBL screening  was done for Enterobacteriaceae isolates 
(Klebsiella spp, E Coli, Proteus spp) according to CLSI guidelines. In this study 
among the 21 Klebsiella spp  isolates 10(47.6%) were  suspected to be ESBL 
producer, among 14 Proteus spp,  7 (50%)isolates  suspected to be ESBL 
producer, and among 8 E Coli isolates 5(62.5%) isolates  found to be ESBL 
producer.(Refer table;14)  
                    In this study, Phenotypic confirmation done for all the ESBL 
producing strains (n=22) according to CLSI guidelines by combined disk 
method. All the 22 strains were confirmed that, all are ESBL producers.(Refer 
table:14)   
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TABLES 
TABLE NO:1 PERCENTAGE OF TOTAL CASES 
PARAMETERS 
NO OF 
CASES(n=137) 
PERCENTAGE 
TOTAL NO OF CULTURE 
POSITIVE 
116 85% 
TOTAL NO OF CULTURE 
NEGATIVE 
21 15% 
TOTAL NO OF CASES 137 100% 
 
 
 
TABLE NO :2  NATURE OF INJURY IN CULTURE POSITIVE 
CASES. 
NATURE OF INJURY 
NO OF 
CASES(n=116) 
PERCENTAGE 
ROAD TRAFFIC 
ACCIDENTS 
84 72% 
SELF FALL 24 21% 
WORK SPOT INJURY 4 4% 
OTHERS(ANIMAL 
ATTACK) 
3 2% 
ASSAULT 1 <1% 
TOTAL 116 100% 
 
 
73 
 
 
 
 
TABLE NO:3   DISTRIBUTION OF ONSET OF INFECTIONS. 
Onset of Infection 
No of cases 
(n=116) 
Percentage 
Early/Acute  Infection 91 79% 
Delayed infection 16 13% 
Late/Chronic infection 9 8% 
Total 116 100.0 
 p Value – 0.047 (Chi-Square test was used to calculate the p-value). 
 
 
TABLE NO:4  DISTRIBUTION OF TYPE OF FRACTURE 
TYPE OF FRACTURE 
NO OF 
CASES(n=116) 
PERCENTAGE 
OPEN/COMMINUTED 
FRACTURE 
82 71% 
CLOSED FRACTURE 34 29% 
TOTAL 116 100% 
 p Value – 0.049 (Chi-Square test was used to calculate the p-value). 
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TABLE NO :5 TYPE OF SURGERY 
Type of surgery No of Cases(n=116) Percentage 
Emergency surgery 74 64% 
Elective surgery 42 36% 
Total 116 100% 
 p Value – 0.042 (Chi-Square test was used to calculate the p-value). 
 
 
 
TABLE NO:6 DISTRIBUTION OF RISK FACTORS 
 
RISK FACTORS/CO-
MORBID ILLNESS 
NO OF CASES  
(n=116) 
PERCENTAGE 
DIABETES MELLITUS 42 36% 
SMOKING 26 23% 
ALCOHOLISM 25 21% 
ANAEMIA 9 8% 
SHT/CKD/CLD 8 7% 
NO RISK FACTORS 6 5% 
TOTAL 116 100% 
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TABLE NO: 7 AGE-WISE DISTRIBUSION OF CASES 
 
 
 
 
TABLE NO;8 GENDER DISTRIBUTION OF CASES 
Gender 
No  of      
Cases(n=116) 
Percentage 
Males 87 75% 
Females 29 25% 
Total 116 100% 
 
 
 
 
 
 
AGE NO OF ODRI(n=116) PERCENTAGE 
5-15 YRS 5 4% 
16-25 YRS 20 17% 
26-35 YRS 21 18% 
36-45 YRS 35 31% 
46-55 YRS 23 20% 
55-70 YRS 12 10% 
TOTAL 116 100% 
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TABLE NO :9 SPECTRUM OF ORGANISMS IN ODRI 
 
 
 
  
Organism Isolated No of Cases(n=116) Percentage 
Staphylococcus aureus 34 29% 
Klebsiella spp 21 18% 
Pseudomonas aeruginosa 15 13% 
Proteus spp 14 12% 
CoNS 9 8% 
E Coli 8 7% 
Acinetobacter spp 3 3% 
Enterococcus fecalis 1 <1% 
Polymicrobial 11 9% 
Total 116 100% 
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TABLE NO :10 ANTIBIOTIC  SENSITIVITY  PATTERN OF  
GRAM POSITIVE ORGANISMS 
 
 
S.No Antibiotics 
Staphylococcus- 
auerus (34) 
Coagulative –
Negative- 
Staphylococcus(9) 
Enterococcus- 
Faecalis (1) 
1 Erythromycin(E) 17(50%) 2(22.2%) - 
2 Amoxycillin(AMX) 20(59%) 7(77%) - 
3 Doxycycline(DO) 15(44.%) 1(11.1%) - 
4 Gentamicin(GEN) 20(59%) 5(55.5%) - 
5 
Co-trimoxazole 
(COT) 
5(15%) 5(55.5%) - 
6 Ciprofloxacin(CIP) 5(15%) - 1(100%) 
7 Cephalexin(CN) 20(59%) 2(22.2%) - 
8 Cephazolin(CZ) 26(76.%) - - 
9 Cefoxitin(CX) 11(32%) - - 
10 Clindamycin(CD) 19(56%) 4(45%) 1(100%) 
11 Linezolid(LZ) 34(100%) 9(100%) 1(100%) 
12 Vancomycin(VAN) 34(100%) 9(100%) 1(100%) 
13 
Amoxycillin –
clavulanic acid 
(AMC) 
- 8(89%) 1(100%) 
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TABLE NO: 11 PERCENTAGE OF MSSA AND MRSA 
S.aureus ISOLATES 
(n=34) 
MSSA  
PERCENTAGE 
MRSA 
PERCENTAGE 
34 23 (67.7%) 11 (32.3%) 
 
 
 
 
TABLE NO: 12 GENOTYPING – PERCENTAGE OF mecA GENE 
MRSA 
STRAINS 
(n=11) 
GENOTYPING BY PCR 
Percentage of  
mec A gene 
Positive 
Percentage of  
mec A gene Negative 
11 90.9% 9.1% 
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TABLE NO:13 ANTIBIOTIC  SENSITIVITY  PATTERN OF  
GRAM NEGATIVE ORGANISMS 
 
 
 
 
  
S.No Antibiotics 
Klebsiella- 
Species 
(21) 
Pseudomonas
- 
Aeruginosa 
(15) 
Proteus- 
Species 
(14) 
E.coli (8) 
 
Acinetobacter 
(3) 
1 
Amoxycillin 
(AMX) 
5 
(23.8%) 
- 
1 
(7.1%) 
2 
(25%) 
- 
2 
Cotrimoxazole 
(COT) 
5 
(23.8%) 
- 
1 
(7.1%) 
1 
(12.5%) 
- 
3 
Gentamicin 
(GEN) 
10 
(48%) 
7 
(47%) 
3 
(21.4%) 
2 
(25%) 
- 
4 
Amikacin 
(AK) 
21 
(100%) 
15 
(100%) 
12 
(85.7%) 
7 
(87.5%) 
1 
(33%) 
5 
Ciprofloxacin 
(CIP) 
16 
(76%) 
7 
(47%) 
7 
(50%) 
7 
(87.5%) 
- 
6 
Cephalexin 
(CN) 
3 
(14.2%) 
- - 
1 
(12.5%) 
- 
7 
Cefotaxime 
(CTX) 
6 
(28.5%) 
3 
(20%) 
5 
(35.7%) 
2 
(25%) 
- 
8 
Ceftazidime 
(CAZ) 
2 
(9.5%) 
11 
(73.%) 
7 
(50%) 
3 
(37.5%) 
- 
9 
Piperacillin-
Tazobactum 
(PIT) 
3 
(14.2%) 
10 
(67%) 
9 
(64%) 
1 
(12.5%) 
3 
(100%) 
10 
Meropenem 
(MRP) 
21 
(100%) 
15 
(100%) 
14 
(100%) 
- 
3 
(100%) 
11 
Tobramycin 
(TOB) 
- 
8 
(53%) 
- - 
2 
(66%) 
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TABLE NO:14 PERCENTAGE OF ESBL 
ISOLATES 
NO OF 
ISOLATES 
COMBINED 
DISC TEST 
POSITIVE 
PERCENTAGE 
OF ESBL 
E.COLI 8 5 62.5% 
PROTEUS 14 7 50% 
KLEBSIELLA 21 10 47.6% 
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DISCUSSION 
               This  study  was  conducted  on patients with orthopaedic implant 
infections  admitted  in  orthopaedic and plastic surgery wards, Coimbatore 
Medical College Hospital, Coimbatore. Of the 1987 patients who underwent 
orthopaedic implant  surgeries  for bone fractures and joint replacement, 137  
patients developed implant infection and they were included in this study. The 
purpose of this study is to isolate the bacterial pathogens causing implant 
infection and to  know  their  resistance pattern  with  reference  to  Methicillin   
sensitivity/resistance and ESBL production. 
               The  isolates  and  the pattern of  their  susceptibility  and resistance 
to the antibiotics  are  continuously  changing.  So periodic survey  of  isolation  
and  the  susceptibility  pattern  of  isolates,  in patients with implant infections  
become essential.  
INCIDENCE  OF  INFECTION: 
               Of the 1987 patients who underwent orthopaedic implant  surgeries  
for bone fractures and joint replacement, 137  patients developed implant 
infection  (6.8%) , which correlates with the study by Ravikanth das et al(2015) 
, Angappan  perumal et  al  (2016)20,21. Among  137 cases, 116(85%) have been 
culture  positive and 21(15%) cases were culture negative, which correlates with 
the study by   Trupti  B .Naik  et  al  (2016).  23 
               Most  of  the  studies  specify  that   the  currently   incidence  of  
ODRI’s  should   be   <  1-2 %  . But  the  incidence of  culture  positivity  in 
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the  present  study  is  relatively  higher  than  the   accepted   standards  .The  
higher  percentage  of  infection  in  our  study  could  be  attributed  to  the  
following  reasons: 
1) Majority of the patients were operated  due to trauma, and it has been 
reported that pre-operative soft-tissue damage is a major risk factor for 
developing ODRI 
2) The other  important risk factors for developing ODRI is   an  emergency 
operation.  
3) In our study, more number of  patients had undergone emergency surgery  
                In contrast ,  low incidence of   implant  infection(2.55%) was 
observed by Fahed A. Al-Mulhim et al in his study  ( 2014) 22.  
NATURE  OF  INJURIES: 
Fractures  following  RTA(road traffic accident) constitutes about  72%  , of  
the total  116  culture  positives  were  encountered in  this  study  that   correlates   
with  the  study  of   Angappan  perumal et  al  (2016), Anisha  fernandes  et  al  
(2013).21, 24  
  The  percentage  of   implant infection was   high  in  RTA , as  this  causes  
extensive  soft  tissue  injury ,  wound  contamination  and  devascularisation of  
periosteum   following   fractures  that leads  to  infections. 24, 25                         
ONSET OF INFECTION: 
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                      ODRI’s  showed  culture  positivity in  79%  of   acute/early onset  
( < 3months after surgery)   cases    and  13%  in  delayed  infection  and  8%  
in  chronic  infection  in the  present  study  .   Similar incidence was quoted by 
A.D Koshravi et al 2009(72.9%, 22.6%, and 4.5% respectively) . 26                
  This  high  prevalence  of early infection  may be related to  
1. Inadequate disinfection procedures to eliminate microorganisms from 
the environment,  
2. Contamination of surgical instruments and /or contaminated implants. 
3.  In addition to that, trauma and fracture fixation using metallic implants 
may produce structural and functional  damage to the local host tissue 
resulting  in impaired  humoral and cellular immune  response.  
On a local level this may decrease resistance to the pathogenic microbial load 
with subsequent manifestation of infection in the traumatized tissue and put the 
patients at a  higher  risk  of  early  infection . 
Type of fracture: 
                 Out  of  116   cases,  82  (71%)  had  open  fracture  and  34 ( 29%) 
had closed fracture. The  incidence  of  infection  was  more  in  open  fracture 
when  compared   to  closed  fracture  that   correlates  with  the  study of    
Prakash  Doshi et al  (2016), and   Angappan  perumal   et al (2016) .27, 21 
                  The   cause  for  increased  infection  in  open  fractures  can  be  
attributed  to   the   fact,  that  skin is normally a barrier to outside contaminants, 
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indwelling  organisms . However when the skin is broken at the time of injury, 
bacteria both from skin  of  the  individual  and  outside  environment  can  easily  
travel  down  to  the broken bone and cause  infection. This   is  the basics   in   
pathophysiology  of  open fractures. 
 IMPLANT INFECTIONS BASED  ON  THE  TYPE  OF  SURGERY:    
                        Out   of   116  cases ,   74 (64%)  had  undergone emergency 
surgery and 42 ( 36%) cases  had  undergone elective surgery   .  In this study 
it was found that ODRI was more common in patients who have undergone 
emergency surgery as compared to less incidence of ODRI in elective surgery    
that  correlates  with   study  of  Ta Wei Kevin Kok et al (2016) . 28 Higher rate 
of infection in emergency surgery was due to  various  factors  such as the 
following: 
1. poor general condition of patient, 
2.  contamination  at the surgical site,  less preparation time for surgery, 
inadequate preoperative optimisation of co-morbidities(anaemia, 
diabetes etc) and  not giving any prophylactic antibiotics. Ta Wei Kevin 
Kok et al (2016)in his study, he  observed that increased incidence of 
ODRI was in emergency implant surgeries.  
Risk factors: 
                     Diabetes  mellitus   n= 42(36%) was  considered  as   an  important  
risk factors for ODRI, which  was  comparable to the study by Angappan 
Perumal et al (2016) , Ta Wei Kevin Kok et al (2016)  .21, 28He also   He also 
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noted  in  his study  that prolonged surgery time was another risk factor for 
ODRI. In our study, in addition to  diabetes  , alcoholism   and  smoking   were  
also  noted  as  risk  factors  for   ODRI’s. 
The pathogenesis of Diabetes in causing wound infection in implant surgeries 
is mainly due to the hyperglycaemic state that impairs neutrophil chemotaxis 
and phagocytosis, resulting in weakened  antibacterial defence and impaired 
wound healing. Suboptimal glucose control peri-operatively is associated with 
increase in the length of the hospital stay, so optimising blood sugar level peri-
operatively becomes essential to decrease the postoperative adverse outcome. 
AGE-WISE DISTRIBUTION OF CASES: 
              In this study, patients were divided into six  different age groups. Out 
of 116,  a  maximum  of  35(31%) patients  are in 36-45 years age group, This 
high percentage of implant infections in this age group mainly due to : 
1. More number of  actively working population  (36-45 years)  
2. Young adults are more involved in RTAs, they exhibit increased risk 
behaviour for RTA(drunken driving, rash driving etc) 
It is comparable to that of study by Angappan Perumal et al(2016), who showed 
high incidence of  ODRI  in 21-60 years age. 21 
GENDER DISTRIBUTION OF CASES: 
               In the 116 infected cases, 87 (75%)  patients  were male and 29 (25%) 
were females. This high male predominance can be attributed  to, 
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1) Men are more prone for trauma because they   travel  outside  for work  
frequently such as to construction sites, industries, factories etc 
 
Our  study  correlates  with the study conducted by Angappan Perumal et 
al(2016), who have recorded 85.96% male and 14.03% females and   
Muhammad Salman et  al  ( 2014 ). 21 , 29 
CORRELATION  BETWEEN  ANTIBIOTIC  PROPHYLAXIS  AND  
ODRI’s : 
                         The  patients  with  preoperative  antibiotic  prophylaxis  
developed  less  implant  infection  (32%)  when  compared  to those  without  
antibiotic  prophylaxis which  was   (62% )  that  correlates  with  the  study  of  
Muhammad  Shoaib  Khan et  al  (2008) . In  contrast  the  study  by  Trisha 
N.Peel  et  al  (2012)    showed  the  percentage  of  implant  infection  was high  
in patients   even  with  antibiotic  prophylaxis  (63%) ,  which could  be  due  
to  the  local  prevalence  of   wide   spectrum  of   pathogens  involved  in 
ODRI’ s . 32, 31 
POLYMICROBIAL INFECTION: 
               Among 116 culture positive cases, 105(90.5%) isolates were mono 
microbial and 11(9.5%) were poly microbial. Study by Juan C. Martinez-Pastor 
et al (2009), showed 59.5%  of  polymicrobial. Another  study by Trisha N.Peel 
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et al (2012) showed   Poly microbial infection(36%) frequently involved 
combination of Gram negative  and  Gram  positive  organisms.  
In our study commonest association was found between Staphylococcus aureus 
and Klebsiella species. 30, 31 The  reasons for polymicrobial in ODRI could be 
due to: 
a) Human endogenous flora contaminating the wound frequently causes 
poly microbial infection. 
b) The biofilm forming organisms were commonly associated with 
polymicrobial infections . 
SPECTRUM  OF  ORGANISMS  IN  ODRI ‘s :  
          Out  of 116 culture positive cases,  Staphylococus aureus  was  the  most 
common pathogen  isolated 34(29%), followed by  Klebsiella spp 21(18%), 
Pseudomonas aeruginosa15(13%), Proteus spp 14(12%), CONS 9(8%), E Coli 
8(7%), Acinetobacter 3(3%), Enterococcus fecalis 1(<1%) and polymicrobial 
11(9%).  
 This  correlates  with  the  study  of   Roopa  shree  et al,  in  2015  at  Bangalore 
25  and  Dr Lakshmi narayana  et al,  in  2013. 
In this study, Gram positive cocci  S. aureus was the most common isolate , 
followed   by  Gram negative bacilli Klebsiella spp. This mainly supports an 
intra operative contamination and assumed that these were the main nosocomial 
pathogens in the operating  room. 
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GRAM  NEGATIVE BACILLI:  
 In  our  study,  among  the  61  isolates  of  gram  negative  bacilli,  21  klebsiella  
species,  15  Pseudomonas  species,  14  Proteus  species,  8  E.coli  species  and  
3  Acinetobacter  species  were  isolated.  Majority  of  the  gram  negative  
bacilli  in  our   study  showed  100%  sensitivity  to  Meropenem  and  80-90%  
sensitivity  to  Amikacin,  60%  sensitivity to  ciprofloxacin,  Cefaperazone-
sulbactam  and  Piperacillin-Tazobactam.   
This  correlates  with  the  study  of  Ravi kant  das  et al,  and  Anirudh  dash 
et al  in  2015  which  showed  a  similar  sensitivity  pattern. Gram  negative  
bacilli  are  common  in  Implant  infections  which  could  be  due  to   
1. Prolonged  stay  in  the  hospital  wards 
2. Cross-infection.32    
Anaerobes:  Though  anaerobes play a significant role in the pathogenesis of 
implant infections, no anaerobes were isolated in this study, the reason could be 
a) anaerobes usually involved in  late/ chronic infections(>24 months), in this 
study, only less number of cases (9 cases) were of  chronic infection.b) 
antimicrobial therapy should be stopped at least 2 weeks prior to the tissue 
sampling for anaerobic cultures. But most of the patients were already on an 
empirical therapy  or they had a history of an antimicrobial treatment in the 
recent past. Other reasons may be  need   better sample collection method by  
avoidance of swabs, inoculation of multiple plates, and longer incubation period 
for better isolation of anaerobes.    
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               Gram positive bacteria showed 100% sensitivity to Linezolid and 
Vancomycin  and  76%  sensitivity  to  Cephazolin .   
All  all the Gram negative bacilli and Pseudomonas showed 100% sensitivity to  
sensitivity  to  Meropenem . 
                The most common Gram positive bacteria isolated in this study was 
Staphylococcus aureus 34(29%) which showed 100% sensitivity to Linezoild, 
and Vancomycin. Cefazolin showed sensitivity of 76%.  Cefoxitin sensitivity 
was 32%.  Drugs such as Ciprofloxacin, Cotrimoxazole showed only 15% 
sensitivity.   
S.aureus  was  higher  in  our  study  which  could  be  due  to   
1. Intra-operative  contamination   
2. Inoculation  of  skin  where,  S.aureus  is  a  commensal.34 
               Coagulative negative Staphylococcus species (n=9) showed 100% 
sensitivity to Linezolid, and Vancomycin.  Enterococcus fecalis (n=1) isolated 
in this study showed 100% sensitivity to Amoxycillin-Clavulanic acid, 
Ciprofloxacin, Clindamycin, and Vancomycin. 
               MRSA isolated  in this study was 11(32.3%) and MSSA 23(67.7%). 
This  correlates with the study by Goel et al (2013). In his study, he observed 
that MRSA was 30%, but in contrary, study by Satya Chandrika V et al(2016) 
showed MRSA was about 64%. 
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               The best evidence for antibiotic selection is available for 
Staphylococci.  All MRSA strains showed 100% sensitivity to Linezolid and 
Vancomycin. In case of Rifampicin resistance, Moxifloxacin can be used as 
monotherapy. In case of MRSA, alternative to beta-lactams, Vancomycin or 
Daptomycin, may also be used and is  well tolerated.  Rifampicin is of crucial 
importance in the treatment of ODRI,  as an   anti-Staphylococcal  biofilm  
antibiotic,  and  has  been  associated  with a high  rate  of  treatment   success.  
But  Rifampicin  should  not be given as mono  therapy  due  to  rapid  
development  of  drug  resistance.  Initially it is administered along with a bêta-
lactam antibiotic, later combined with a quinolone especially with 
Ciprofloxacin or Levofloxin.         
            Study by  T. Fintan Moriarty et al( 2016) reveals that  in case of 
quinolone resistance, Rifampicin can  be given along with Fusidic acid,  
Cotrimoxazole,  Linezolid,  Clindamycin or  Minocycline.  
Local antibiotic delivery: 
            It has been described since 1970s, certain biomaterial  may  be  used as 
carriers  or  vehicles,  for  the  delivery  of  antibiotic  agents to  the  site of 
infection  and  of late  it  also  has  become  a  regular  adjunct  in  the  treatment 
of ODRI. Local delivery of drugs has many advantages over systemic delivery, 
which can offer for the potential for significant supportive antimicrobial effect. 
Since the antibiotic is placed directly at the site of interest, an intact  vascular 
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system  is  not  required  to  reach  the  surgical site,  which  may  be  particularly 
useful in trauma patients. 
             Local delivery can also achieve local concentrations much higher than  
those achievable systemically, thereby not only improving local concentration, 
but  reducing  the  risk  of  systemic  toxicity.  Bone cement is a ideal  vehicle  
for antibiotic delivery and Gentamicin was identified as suitable antibiotic due 
to the fact that it was found to withstand   the elevated temperatures of curing 
bone cement. Antibiotic- loaded bone cements  are useful in  improving  ODRI 
outcomes.  
New approaches for prevention and treatment: 
1) Active and passive vaccines: based on its cost effectiveness, 
vaccination is an important  approach to prevent, treat and potentially 
eradicate ODRIs. But unfortunately, all efforts to develop an effective 
vaccine against S. aureus  have  failed  for  a number of reasons. The 
main reason is that S. aureus has co-evolved with mammalian hosts to 
become a human commensal. Thus all patients have some level of 
acquired immunity against  S.aureus prior to surgery. Measurement of 
the immune response against S. aureus may help guide future 
prophylaxis and therapy. 
2) Silver: Silver is a potent candidate for coating devices, as it gives a broad 
spectrum of antibacterial activity against planktonic and sessile Gram 
positive, Gram negative and multi drug- resistant bacteria. 
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3) Antimicrobial and anti-biofilm peptides: Antimicrobial 
peptides(AMPs) are innate defence molecules of animals, plants and 
microorganisms, with a broad spectrum of antimicrobial activity and low 
risk of resistance development in general.  
4) Quorum- sensing  inhibitors:  Quorum sensing is a mechanism that 
many microorganisms use to coordinate gene expression in response to 
local conditions, including cell density. Combining conventional 
antimicrobial agent with a quorum sensing inhibitor might circumvent 
the problem of biofilm tolerance. 
5) Biofilm degrading enzymes:  Anti-biofilm strategy depends on the use 
of biofilm-degrading enzymes, and both deoxyribonuclease1(DNase 
1)and exopolysaccharide-degrading dispersion B(DspB),   could have 
applications in the prevention or treatment of biofilm infections 
associated with orthopaedic implants. 
All these emerging technologies and interventions may be expected to 
improve  in  the  successful   treatment  of  ODRIs  in  future. 
  Phenotyping of Methicillin resistance Staphylococcus aureus was done using 
Cefoxitin(30µg) disc according to CLSI guidelines. Genotyping by PCR was 
done for all MRSA strains to identify Staphylococcal chromosomal cassette 
(SCC)mec elements that contains chromosomal gene mecA which encodes for 
penicillin binding protein 2A(PBP2A).   
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          Out of 11 MRSA isolates, 10 isolates (90.9%) were  positive for mecA 
gene. A  single  isolate  was  negative for mecA gene  and   could  be  due to 
the presence of other resistance mechanisms such as  
1) large amounts of  beta-lactamase  or  
2) lack of  optimal PCR conditions or  
3) change in mecA gene due to mutations. 
              Mec A  gene  detection  by  PCR  method  is  the  gold  standard  for  
identifying  methicillin  resistance  in  S.aureus  isolates. Mec A gene  is  present  
in  MRSA  strains  which  encodes  penicillin  binding  proteins (PBP 2a).  
MRSA  has  become  a  major  public  health  problem  all  over  the  world.  It  
is  correlated  with  increased  morbidity,  compared  to  other  bacteria. 
              Mec A gene  was  found  in  10  out  of  11  MRSA  isolates  in  our  
study. 
              In  a  health  care  setting  MRSA  infections  can  cause  severe  
problems  in  a  hospital  or  nursing home, such as   blood stream  infections,  
pneumonia,  and  surgical  site  infections.  MRSA  infections,  if not diagnosed 
and treated early  can cause severe sepsis and mortality.  
             MRSA is  usually  spread  by  (1) direct  contact  with  a  patient  with  
MRSA   infection  or  colonisation   
2)  Hand hygiene  -  Not following  proper  hand washing  and use  of  PPE   
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3)  From a health care personal / Nasal carriage.   
                   Also nasal carriage of MRSA in people who   do  not  have  signs  
and  symptoms  of  infection, can  spread  the  bacteria  to  others.   Studies  
shows  that  about  33%  of  people  are  nasal  carriers  of MRSA.  CDC  study  
in  2011,  also  showed  morbidity  and  mortality  due to  MRSA  isolates. 
CDC  guidelines   to  combat  antibiotic    resistance  plan  for  MRSA:- 
1. To  know  the  type  of  drug - resistant  infections  present  in  your  
facility  and  patients. 
2. Request  immediate  alerts  when  the  laboratory  identifies  drug-
resistant  isolates. 
3. Alert  the other  facility  when  you  transfer  a  patient  with  drug-
resistant isolates. 
4. Follow  relevant  guidelines  and  precautions  at  every  patient  
encounter  like  appropriate  handling  of  patient  care,  equipment / 
devices. 
5. Follow appropriate antibiotic policy. 
6. Removal  of   temporary  medical  devices  as early, especially when  it  
is  not  needed.           
           
  
  
 
 
 
 
 
 
 
 
 
 
 
SUMMARY 
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SUMMARY 
               The  present  study  was  carried  out  in  the  Department  of  
Microbiology in  collaboration  with  the  Department  of  Orthopaedics,  
Coimbatore Medical college, Coimbatore  for  a  period  of  one  year   from  
July 2016- June2017.  
                In  this  study,   116  culture   positive   isolates    were  identified     
including   Gram   positive  cocci  and  Gram  negative  bacilli  from  orthopaedic  
implant  infections.   MRSA  strains   and  ESBL  production   by  Gram  negative  
bacilli  were    detected   by  phenotypic  methods  and  molecular  
characterization  by  PCR  for  MRSA  strains. 
1) A  total   of  137  clinically  suspected   cases  of  orthopaedic  device  
related  infections(ODRI’s)   were  studied  in  all  age  groups,  and  in  
both  sexes  irrespective  of  pre- operative  administration  of   antibiotics  
in  patients  who had  undergone  implant  surgery. 
2) Out  of  137   ODRI’s , culture  positivity  was  found  in  85% . 
3) Age  predilection  for  ODRI was  found  to  be  common  in  36-45  year  
age group. 
4) ODRI ‘s  were  predominantly  seen  among  males   than  females in a  
ratio   of    2.9  :  1. 
5) Among  the  nature  of  injuries,  more  number  of  cases(68%)  were  
due  to  road  traffic  accidents(RTA)  . 
6) Regarding  the  onset  of  infections,  majority  of  the  patients(76.6%)  
had  early/acute  onset  of  infection  . 
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7) In  the  present  study  implant  infection  with  open  fracture  was  found  
to  be  high  (68.6%)  as  compared  to  closed  fracture  . 
8) The  present   study  reveals  , those  who  had  undergone  emergency  
surgery (64%)  had  developed  implant  infections  more ,  when  
compared  to  elective  surgery(36%) . 
9)   The  most  common  risk  factor  was  found  to  be  diabetes mellitus  
(36%)  followed  by  smoking (23%)  and  alcoholism(21%).   
10) Out  of   116  patients  ,  the  culture  positivity  developed  by  patients  
with  preoperative  antibiotic  prophylaxis  was  less  (38%)  when  
compared  to those   without  antibiotic  prophylaxis  which  was  more   
(62%)  . 
11)  Among  the 116  culture  positive  cases,  105  isolates  were    
monomicrobial    and  11  isolates  showed  polymicrobial  growth. 
12) Among  the  105  monomicrobial  isolates,  44  isolates  were found  to  
be  Gram  positive  cocci,  and  61  isolates  were  found  to  be  Gram  
negative  bacilli.   
13) Staphylococcus  aureus  is  the  most  common  Gram  positive  cocci  
34(77.2%) isolated  and  Klebsiella  spp is the  most common isolate 
among Gram  negative  bacilli   21(34.4%).  
14) Out  of  34  isolates  of  Staphylococcus  aureus  11  isolates  were  found  
to  be  MRSA  strains  which  is  about  32.3% 
15) ESBL  screening  was done  for  all   Klebsiella spp,  Proteus spp, and 
E  Coli isolates.  Out  of  61  Gram  negative  isolates,  22  isolates  
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(Klebsiella-10,  Proteus-7,  and E Coli-5)  were  found  to  be  ESBL  
producers. 
16) Phenotypic  confirmation  test  was  done  for  all  the  22  ESBL by 
combined disk diffusion  method and  all  22  strains  were found to be  
ESBL  producers. 
17) Genotyping  done  for  all   11  MRSA  strains,  out  of  11 MRSA  strains  
10  isolates  found  to  be  positive  for  mecA gene.                      
                             
.  
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CONCLUSION 
            Orthopaedic device related infection (ODRI) is a diagnostic and 
therapeutic challenge which can pose a serious threat to the patient leading to 
high morbidity. This study has given us a wide knowledge about ODRI and 
their incidence in our hospital and also helps us in finding out the 
bacteriological profile of organisms causing implant infection and their 
sensitivity pattern. 
           The infection rate in primary orthopaedic surgery as found in our study 
is comparatively high and so there is need for proper measure of infection 
control as it has great financial burden on patient and on hospital resources and 
could lead to increased morbidity and mortality in patients. 
           While analysing risk factors , Diabetes  mellitus  was  the  most common  
co-morbid entity for ODRI’s, hence preoperative  glycemic  control  is  essential  
before  planning  for  surgery. Next  to  diabetes ,  Alcoholism  and  smoking  
were  considered  to  be  a  definitive  risk  factor  for  developing  implant  
infection. 
            Among the culture positive cases, Staphylococcus aureus was found to 
be most common Gram positive isolate and Klebsiella species as the 
predominant Gram negative isolate. 
             Treatment of ODRI  is a scenario where many variables play a role in 
deciding the treatment. The treatment however is difficult and prolonged. 
Therefore, the best treatment strategy is prevention of infection. Antimicrobial 
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prophylaxis remains the single most effective method of reducing the 
prevalence of infection.  
            Treatment of ODRI requires prolonged antibiotic treatment of a 
minimum of    2 weeks  upto  6 months. The choice of the antibiotic regimen 
depends on duration and pathogenesis of   infection, stability  of  the implant  
and antimicrobial susceptibility  of the pathogen.   
            In most instances, empirical treatment is being given for ODRI cases. 
Inappropriate and misuse of  antibiotics  can  cause  multidrug  resistance to 
commonly used antibiotics. Thus usage of antibiotics should be based on local 
and current trends on prevalent pathogens and its sensitivity pattern.  
            This  study  clearly  shows  the  changing  trends  of  microbial  isolates  
with  special  emphasis  on  the  emergence  of  MRSA  and  ESBL  strains  in  
our  hospital  set-up.  The  diagnostic  microbiology  thus  plays  a  crucial  role  
in this  context  and  aids  the  surgeons  in  the  proper  selection  of  antibiotics  
as  per  the  Antibiotic  policy  guidelines  issued  by  Hospital  Infection  Control  
Committee.  
             With the evolution of newer techniques such as arthroscopy, recent 
advances in trauma and fracture management,  introduction of the modern 
arthroplasty, and spine surgeries, the risk of  infection is a great threat. We all  
know  that implant infections and osteomyelitis might just be the most difficult 
morbidities to treat  and  patients with osteomyelitis may even land up in 
amputations.  Hence It is always better to prevent the development of implant 
infections  and take appropriate  to prevent ODRI.     
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